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GLOBAL HEALTH COVID-19 PRACTICE GUIDELINES
Last updated June 30, 2020

Executive Summary
This document will be regularly updated to include links and brief summaries of practice guidelines for
managing COVID-19 patients. They emphasize safe practice to prevent healthcare worker infection, as well as
recommendations on what care may be deferred or even performed remotely through videoconferencing. We
include a section on general recommendations as well as specific recommendations and guidance by medical
practice area.

General
•

Helping couples to preserve relationships during COVID-19 pandemic
Family Process: The authors focus on strategies that therapists and relationship educators can use to help couples preserve
and protect their relationships. They describe 4 foundations of safety that allow relationships to thrive: physical, emotional,
commitment, and community. 3 keys from their body of work are highlighted that can help guide individuals and couples in
protecting their relationships on a day-to-day, moment-to-moment basis: 1) Decide, don't slide. 2) Make it safe to connect. 3)
Do your part.

•

Brazilian guidance on breastfeeding during the Covid-19 pandemic
Rev Assoc Med Bras: Brazilian authors analyzed 20 recent publications on breastfeeding and Covid-19 and found the
evidence that an infected mother can pass the virus through respiratory droplets when in contact with the child, including
during breastfeeding. They suggest the following precautions: Washing hands for at least 20 seconds before touching the
baby or extracting breastmilk (manual extraction or by pump). Wearing a face mask and avoiding talking or coughing during
breastfeeding. Immediately changing masks in case of coughing or sneezing, or at every feeding. Strictly follow the
recommendations for cleaning the pumps for milk extraction after each use according to the manufacturer’s specifications.
Consider the possibility of asking for help from someone who is healthy to feed the newborn with the breastmilk using a cup
or spoon.

•

Novel design for the door handle: using forearms instead of hands to reduce contamination
The American Journal of Medicine: The authors describe a device to avoid COVID-19 disease transmission from door handles
by augmenting the regular design with an extension. This design allows individuals to pull the door open with their forearms
instead of their hands, as forearms are rarely used to touch peoples' faces.

•

Infectious Diseases Society of America guidelines on the diagnosis of COVID-19
Clinical Infectious Diseases: Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology
was used to assess the certainty of evidence and make testing recommendations. The panel agreed on an algorithm for
SARS-CoV-2 Nucleic Acid Testing and on 15 diagnostic recommendations.

•

The shortcomings of restricted hospital visitation
Pediatric Critical Care Medicine: The authors from the University of Michigan Medical Center warn that severely restricted
visitation policies undermine our ability to provide humane, family-centered care, particularly during critical illness and at the
end of life. The enforcement of these policies consequently increases the risk of moral distress and injury for providers. The
authors surveyed the shortcomings of current visitation restrictions. They argue that hospital visitation restrictions can be
implemented in ways that are nonmaleficent, but this requires unwavering acknowledgment of the value of social and
familial support during illness and death. They advocate that visitation restriction policies be implemented by independent,
medically knowledgeable decision-making bodies, with the informed participation of patients and their families.

•

Institutional antithrombotic protocols for COVID-2019

Research and practice in thrombosis and haemostasis: The authors compare different institutional protocols proposed in US
and France. Here are their summary recommendations: Medical floor COVID-19–positive patients: use LMWH (low molecular
weight heparin) at prophylactic or intermediate doses as the preferred agent over unfractionated heparin (UFH), unless
patients have severe renal insufficiency. Patients with severe COVID-19 requiring high-flow oxygen or ventilator: use LMWH
at prophylactic or intermediate doses as the preferred agent over UFH in ICU settings, with serious illness meeting sepsisinduced coagulopathy score of ≥4 or with markedly elevated D-dimer (>6× ULN). Extended thromboprophylaxis: Patients
hospitalized with COVID-19, especially those with an IMPROVE VTE score of ≥4, elevated D-dimer (>2× ULN), or over 60 years
and without bleeding risk factors, or recent ICU stay should be strongly considered for extended thromboprophylaxis up to
40 days after hospital discharge with either lovenox 40 mg s.c. daily, rivaroxaban 10 mg p.o. daily, or betrixaban 80 mg p.o.
daily. Routine empiric therapeutic dose of intravenous UFH or systemic tissue plasminogen activator or routine use of inferior
vena cava filters: No current supporting evidence for its use without absolute indications. Continuation of home
antithrombotic medications or need of chronic antithrombotic: Patients on antiplatelets or oral anticoagulants (OACs) should
be kept on their therapy unless there are absolute contraindications (such as active bleeding, severe thrombocytopenia,
planned procedure, or significant new drug interaction or other contraindications). DOACs are preferred over warfarin for
treatment of VTE or atrial fibrillation due to decreased need for monitoring. Lopinavir/ritonavir may potentiate CYP3A4 or Pgp inhibition, and as such there may be reduction in clopidogrel effects and increased effects of ticagrelor – thus, switch
them over to prasugrel if possible or consider platelet function studies (P2Y12 monitoring). For OACs, if possible, patients
may be switched to dabigatran, edoxaban, or betrixaban from apixaban and rivaroxaban as the DOACs of choice if combined
therapy with CYP3A4 inhibitor is prescribed. Alternatively, dose-adjusted warfarin with frequent INR monitoring should be a
good option.

•

The accumulating burden of non-COVID-19 illness requires attention: Italy data
Internal and Emergency medicine: During the lockdown in a hospital in Milan, the ED admissions dropped from the mean of
2361/month in December 2019–February 2020 to 1102 (− 53%) and 861 (− 63%) in March and April 2020, respectively. The
ED admissions by medical specialties showed a significant drop in traumatology, dermatology, gastroenterology/hepatology
and cardiology, with an increase of accesses for respiratory diseases (from a mean of 12% in previous months to 36% and
29% in March and April 2020, respectively). At the same time, red codes at triage admission doubled (3.9% in March and
2.7% in April 2020) compared to the 1.5% of the prior Internal and Emergency medicine 3 months, with a concomitant
significant reduction of white codes. The authors worn that some clinical conditions will further progress with a significant
increase in morbidity and mortality. A recent study showed that the mortality from acute heart attack in Italy has almost
tripled for late clinical presentation caused by patients avoiding hospitals for fear of SARS-CoV-2 infection, a phenomenon
that is being observed also in other European countries and in the USA. To prevent this, it is essential that patients with
chronic conditions should be at least monitored and managed with telephone or online health consultation, identifying those
who need urgent access to care, prioritizing outpatient visits based on disease severity.

•

Benefits of noninvasive ventilation in the prone position: Italy case series study
A cross-sectional survey was performed to identify 15 inpatients undergoing the prone position with noninvasive ventilation
(NIV, CPAP+O2) outside the ICU. Respiratory parameters were measured at 3 time points: before NIV, during NIV in
pronation (60 minutes after start), and 60 minutes after NIV end. Follow-up was conducted at 14 days. Compared with
baseline, all patients had a reduction in respiratory rate during and after pronation (P < .001 for both); all patients had an
improvement inSpO2 and PaO2:FIO2 during pronation (P < .001 for both); 80% had an improvement in SpO2 and PaO2:FIO2
after pronation; 13.3% had the same value; and 6.7% had worsened. Compared with baseline 73.3% had an improvement in
comfort during pronation and 26.7% had the same value. At the 14-day follow-up, 9 patients were discharged home, 1
improved and stopped pronation, 3 continued pronation, 1 patient was intubated and admitted to ICU, and 1 patient died.
Prevention/delay of intubation wasn't assessed.

•

Portuguese intensive support recommendations
Einstein: Intensive support recommendations for critically ill patients with suspected or confirmed COVID-19 infection are
provided based on the experts' opinion.

•

Multidisciplinary approach to COVID-19 treatment

Clinical Rheumatology: Based on the literature review, the authors propose a management algorithm, integrating
correlations between the clinical COVID-19 features with laboratory and imaging findings to establish the right timing for
each treatment.

•

The Global Research Data Alliance community response to the global COVID-19 pandemic
The RDA COVID-19 Working Group released the 5th edition of recommendations and guidelines including the following
sections: Clinical; Community Participation; Epidemiology; Indigenous Data; Legal and Ethical; Omics; Social Sciences;
Software (pdf found here).

•

Deaf and hard of hearing hospital communication and telehealth services recommendations
The recommendations are provided for hospital communications services (National Association for the Deaf and consumer
groups) (available here) and on Telehealth (available here) for deaf and hard of hearing population.

•

The U.S. Department of Labor issues first COVID-19 workplace guidance for nursing homes
Reuters: The U.S. Department of Labor issued its first workplace guidance to nursing homes on Thursday. It recommended
that they keep residents, staff, and visitors 6 feet apart, screen residents and staff for symptoms, and find alternatives to
group activities. It did not give recommendations for testing of residents or workers by nursing homes.

•

Recommendations on COVID-19 for laboratory professionals
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) provides recommendations on COVID-19
laboratory screening, testing protocols, diagnosis, and other general information for laboratory professionals, including links
to helpful resources and interim guidelines. It will be continually updated as new guidelines and literature become available.

•

Comorbidities as predictors of mortality: systematic review and meta-analysis
The literature review (N=42 studies) showed that the most common pre-existing morbidities in COVID-19 patients were
hypertension (36.5%), cardiovascular disease (11.9%), and diabetes (22.0%). The higher likelihood of deaths was found
among COVID-19 patients who had pre-existing cardiovascular system diseases (OR: 3.32, 95% CI: 2.79-3.95), immune and
metabolic disorders (OR: 2.39, 95% CI: 2.00-2.85), respiratory diseases (OR: 2.02, 95% CI: 1.80-2.26), cerebrovascular system
diseases (OR: 4.12, 95% CI: 3.04-5.58), any types of cancers (OR: 2.22, 95% CI: 1.63-3.03), renal (OR: 3.02, 95% CI: 2.60-3.52),
and liver system diseases (OR: 1.44, 95% CI: 1.21-1.71). This evidence can be used by healthcare providers to stratify patient
risks and prioritize the treatment.

•

Ethical use of off-label drugs
This short communication comments on two major ways of using off-label drugs: 1) in clinical practice or 2) in research, and
in "pseudo-research" approach. Authors reflect on the 4 principles of ethics: autonomy, non-maleficence, beneficence, and
justice. According to WHO, off-label use is justified when the condition is serious and there is evidence of potential benefit,
there is no standard therapy available, patients have been informed and consented (if possible, in written), and the patients
are monitored for safety concerns.

•

Recommendations for acute management of COVID-19
Italian clinicians share their COVID-19 clinical management suggestions, derived from the direct experience of the first 200
patients with acute respiratory failure, with 75 being admitted to ICU while undergoing mechanical ventilation.

•

Recommendations for respiratory protective equipment for health care workers
Discrepancies on guidance from health authorities for health care workers’ respiratory protective equipment (RPE) are
discussed. The authors suggest continuous use of N95 respirators during health care worker shifts. In lieu of the respirators,
constant use of surgical masks during clinical care with suspected or confirmed cases is recommended by the authors.

•

Post-acute rehabilitation for survivors of COVID-19
A summary of evidence on COVID-19 survivors is presented, including comorbidities, complications from an ICU stay +/intubation, and the effects of the virus on multiple body systems. The guidelines are suggested on inpatient and outpatient
rehabilitation unit organization, as well as on physiotherapy, occupational therapy, and other types of rehabilitation for
COVID-19 survivors.

•

No need to discontinue Angiotensin-Converting Enzyme inhibitors and Angiotensin II Receptor blockers
The role of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in the setting of the COVID-19
pandemic is hotly debated. In a retrospective study of 18 472 patients who underwent COVID-19 testing, 12.4% were taking
either ACEIs or ARBs. Overlap propensity score weighting showed no significant association of ACEI and/or ARB use with
COVID-19 test positivity (overlap propensity score–weighted odds ratio, 0.97; 95% CI, 0.81-1.15). The data support current
professional society guidelines to not discontinue ACEIs or ARBs in the setting of the COVID-19 pandemic.

•

Guidance to adjust sarcoidosis management
CHEST Journal: Immunosuppressive therapy for two types of sarcoidosis is discussed. In patients who are in stable remission,
it is recommended to reduce the dose or prolong the dose interval of their immunosuppressive medication. In a patient with
continued, active disease or organ dysfunction, it is recommended to continue treatment at lowest possible dose or current
dose due to the risk of severe unfavorable outcomes.

•

Italian researchers advise oral and nasal use of 3% H2O2 for reduction of COVID complications
Researchers suggest gargling H2O2 thrice daily and nasal washes of H2O2 with nebulizer twice daily at onset of symptoms
and diagnosis. They also advise 1 drop of iodopovidone (0.5 - 0.6%) in each eye thrice daily. Studies have shown no damage
to the mucosa within six months of H2O2 use. They hypothesize that H2O2’s oxidation, mechanical removal properties, and
induction of TLR3 play anti-viral roles. Changes in COVID hospitalizations have yet to be analyzed.

•

WHO guidelines for infection control, protecting health care workers with potential Covid exposures
WHO has provided guidance for the use of medical masks, respirators and other personal protective equipment for
healthcare workers. They also have a data collection instrument to be completed by each health care workers potentially
exposed. These guidelines are periodically updated.

•

CDC recommendations for COVID-19 Infection Prevention and Control in Healthcare Settings
CDC gives recommendations about PPE for individuals transporting patients, health care personnel providing care to exposed
asymptomatic patients evaluated for non-infectious complaint; as well as for environmental personnel who clean rooms of
hospitalized patients with COVID-19. It also provides information on what procedures should be considered as aerosol
generating, on how nasopharyngeal swabs can be performed, and on who should be placed into airborne infection isolation
rooms, as well as other issues.

•

Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards
Virus was found to be widely distributed on floors, computer mice, trash cans, and sickbed handrails and was detected in the
air at about 4 m from patients at a hospital in Wuhan, China. The authors highly recommend disinfection of shoe soles before
walking out of wards containing COVID-19 patients.

•

CDC advice for exposed critical infrastructure workers who remain asymptomatic
Employers should measure the employee’s temperature and assess symptoms prior to them starting work. Regular
Monitoring: As long as the employee doesn’t have a temperature or symptoms, they should self-monitor under the
supervision of their employer’s occupational health program. Wear a Mask: The employee should wear a face mask at all
times while in the workplace for 14 days after last exposure. Social Distance: The employee should maintain 6 feet and
practice social distancing as work duties permit in the workplace. Clean and Disinfect all areas such as offices, bathrooms,
common areas, shared electronic equipment routinely. They should adhere to these practices prior to and during their work
shift. If employee becomes sick during the pandemic.

•

New CDC guidance states critical employee should continue going to work after exposure to possible or
confirmed COVID-19 patients until they become symptomatic
New White House, CDC, and Department of Homeland Security guidance. Critical employees exposed to possible COVID-19
patients but whom do not yet have symptoms should be screened before entering work, monitor for symptoms, wear a cloth
face cover, and practice social distancing.

•

CDC issued guidelines for caretakers of COVID-19 patients staying at home

Guidelines include recommendations for keeping patient as separate from other family members as possible and checking
frequently for signs of worsening condition.

•

A scoring system suggested for “Medically-necessary, time-sensitive" (MeNTS ) procedures
MeNTS is discussed as an alternative to an “election” procedure term. A scoring system is described systematically
integrating multiple factors to facilitate decision-making and triage for MeNTS procedures and appropriately weighs
individual patient risks with the ethical necessity of optimizing public health concerns.

•

CDC launches new podcast on caregivers and unsafe caregiving practices
Caregivers provide crucial support for their care recipient and the health care system but may be compromising their own
health in the process and many are providing "unsafe caregiving".

•

Best practices for healthcare facilities
The FEMA Federal Healthcare Resilience Task Force published the "COVID-19 Hospital Resource Package", which is intended
to provide publicly accessible guidance and tools to better enable the healthcare response to COVID-19. The document
provides guidance on surge planning for the emergency department, critical care, and mortuary services; crisis standards of
care; staffing surge and resilience; workforce protection; regulatory concerns; PPE and healthcare supply chains; and
telemedicine to support US health systems’ efforts to combat the growing epidemic.

•

Applying principles of military leadership to the Covid-19 crisis
The key components of mission command are unity of effort, freedom of action, trust, mutual understanding and rapid
decision making.

•

Youtube discussion of public health strategies and policies related to COVID-19
Rochelle Walensky, MD, MPH of Harvard University discusses public health strategies and policies for lifting shelter-in-place
and quarantine and for returning the U.S. to a new post-first-wave normal.

•

Traffic Control Bundling should be implemented in long term care facilities
Traffic Control Bundling through compartmentalization within zones and active surveillance has been implemented in
hospitals to reduce the spread of COVID-19 and is now being recommended for protecting against and mitigating the spread
of COVID-19 in long-term care facilities.

•

CDC guidelines for healthcare professionals
CDC offers trainings on clinical care and infection control, personal protective equipment, non-pharmaceutical infections, and
emergency preparedness and response specific to COVID-19 to Healthcare professionals.

•

WHO: No extra precautions necessary in washing and preparing produce
WHO states there are no extra steps needed for proper washing of produce; wash them as you would normally: wash hands
with soap and water before handling fruits and vegetables, then wash produce thoroughly with clean water before eating.

•

WHO creates interactive chat to combat misinformation
WHO Viber chatbox allows people to access reliable health information on their mobile device in their local language. The
free service is offered in over 20 languages.

•

Webinar: conducting clinical trials during the COVID-19 pandemics
On 4/30/2020 11-11:45 MDT FDA will discuss the challenges of, and guidance for, supporting clinical trials during the COVID19 public health emergency. Note: This webinar is now full, but the recording of the webinar will be available shortly after the
webinar concludes.

•

Guidelines on how to properly wear a cloth mask in public
Many citizens are concerned that people are wearing masks incorrectly. According to the WHO, the mask should fit snugly
without any gaps. Masks should also cover all of the nose and below the chin. Hands should also be washed prior to putting
the mask on.

•

Risks and benefits of inhaled corticosteroids for severity of disease remains inconclusive

A systematic review found that there is currently no evidence whether pre-morbid use or continued administration of
inhaled corticosteroids has adverse or beneficial outcomes in acute respiratory infections due to coronavirus. Patients with
asthma and COPD who are stable while using inhaled corticosteroids should continue on their treatment.

•

Recommendations for nose bleeding management during the COVID-19 pandemic
Recommendations include: thorough history taking, wearing PPE, performing invasive treatments in operating room or well
demarcated areas, and postponing sphenopalatine artery ligation (for posterior epistaxis) until COVID-19 testing has been
performed. The use of local anesthetic atomized sprays should be avoided, and soaked pledgets should be preferred. A
suction system should be used during the procedure within a closed system with a viral filter.

•

Molecular testing for acute respiratory tract infections: recommendations
The Diagnostics Committee of the Infectious Diseases Society of America (IDSA) conducted a literature review. Compared to
classical culture-and antigen-based methods, molecular tests have high sensitivity and there is potential for a clinically
meaningful turn-around-time to actionable results. Respiratory NAAT is most useful in the setting of intermediate pre-test
probability and intermediate disease severity. This is a situation where a negative test may permit withholding of initial
empiric coverage of a potential pathogen, whereas a positive test can allow therapy to be focused against a particular
pathogen, thus increasing therapeutic efficacy, decreasing avoidable drug-toxicity, and potentially reducing unnecessary
additional testing.

Allergy and Immunology
•

Resources for A/I Clinicians during the COVID-19 Pandemic
American Academy of Allergy Asthma & Immunology (AAAAI) resource page

•
•

American College of Allergy, Asthma & Immunology coronavirus resource page
Acute home anaphylaxis management: expert guidelines
Authors recommend patients to activate their emergency medical services if symptoms don't improve or worsen after
epinephrine administration. Patients are encouraged to have 2 auto-injections at home and replenish as needed. Those with
underlying asthma should maintain asthma control. Telemedicine is a recommended tool for assessment and follow up to
decrease hospital burden and limit COVID-19 exposure.

Anesthesiology and Pain Medicine
•

General anesthesia recommendations for ECT during the COVID-19 pandemic
The Journal of ECT: The Weill Cornell Medicine- New York Presbyterian Hospital Anesthesiology and Psychiatry departments
collaborated to develop guidelines for electroconvulsive therapy anesthesia during COVID-19 pandemic.

•

Update for anesthetists on COVID-19 management
An international group of researchers including from Oxford UK, provides the updated recommendations for anesthetists in
the question-answer format.

•

Sedation of mechanically ventilated COVID-19 patients: recommendations
Management of sedation in ICU patients with COVID-19 is discussed. The emphasis is on taking into account drug’s individual
properties and side effects, unique COVID-19-related patient characteristics (prolonged intubation, virus shedding), and
health care system limitations (large numbers of patients, ICU patients in ER and operating rooms, drug shortages).

•

Pain management in multispecialty organizations: experts guidelines
A pain management expert panel was created from the military, veterans' health administration and academia, in order to
address the issue of the management of chronic pain during the COVID-19 pandemic and public health crises. A set of
guidelines was created that provides a framework for pain specialists and institutions.

•

Recommendations on Chronic Pain Practice during the COVID-19 Pandemic

A Joint Statement by American Society of Regional Anesthesia and Pain Medicine (ASRA) and European Society of Regional
Anesthesia and Pain Therapy (ESRA)

•

Practice Recommendations on Neuraxial Anesthesia and Peripheral Nerve Blocks during the COVID-19
Pandemic
A Joint Statement by the American Society of Regional Anesthesia and Pain Medicine (ASRA) and European Society of
Regional Anesthesia and Pain Therapy (ESRA)

•

Chinese Society of Anesthesiology consensus: Anesthetic management of cardiac surgical patients
Patients who undergo cardiovascular surgery necessitate extremely high demands from anesthesia personnel and face high
risks of mortality and morbidity. Anesthesia management guidelines provided for cardiovascular surgery along with the
prevention and control of COVID-19. Guidelines include: preoperative evaluation and prep, anesthetic prep, intraoperative
management, anesthetic management, and postoperative care.

•

Society for Neuroscience in Anesthesiology & Critical Care (SNACC) guidelines for neuroanesthesia
This consensus statement provides information on the neurological manifestations of COVID-19, advice for neuroanesthesia
clinical practice during emergent neurosurgery, interventional radiology (excluding endovascular treatment of acute ischemic
stroke), transnasal neurosurgery, awake craniotomy and electroconvulsive therapy.

Bone
•

UNM project ECHO response to COVID-19: professional education and bone health guidelines
Project ECHO (Extension of Community Healthcare Outcomes), developed at the University of New Mexico in 2003, is
technology-enabled collaborative learning that uses videoconferencing to expand healthcare workforce capacity, increase
access to specialty level care, and reduce health disparities in underserved communities. There are now at least 825 ECHO
programs addressing a broad range of disease states and conditions, based in 48 states and 39 countries. Project ECHO
responded by temporarily redeploying all staff to activities devoted to best practiceCOVID-19 care forpublic health officials,
scientists, and frontline healthcare workers in the USA and abroad. Bone Health TeleECHO listed guidelines for orthopedic
care during COVID-19 pandemic with an emphasis on osteoporosis. Treatment plans include non-bisphosphonate injections
in drive-thru setting or using nursing home-visits to administer medication. Virtual platforms are offered to address the
canceled conferences across the globe and for patient care. The skills to launch and maintain an ECHO program can be
acquired through no-cost “Immersion training” provided at UNMHSC and in other countries, and now available in an online
format.

Cardiology
•

A personalized cardiometabolic approach for reducing complications and costs: a review
This is the first review, focusing both on cardiovascular and metabolic aspects of COVID-19, in an integrated and personalized
way, following the guidelines of the Cardiometabolic Health/Medicine.

•

Cardiovascular complications in COVID-19: a systematic review and meta-analysis
Journal of Infection: The most frequent cardiovascular complications among patients hospitalized with COVID-19 are heart
failure, myocardial injury, cardiac arrhythmias and acute coronary syndrome The following pathogenetic pathways are
proposed: (i) direct cardiotoxicity; (ii) systemic inflammation; (iii) myocardial demand-supply mismatch; (iv)plaque rupture
and coronary thrombosis; (v) adverse effects of therapies during hospitalization; (vi) sepsis leading to DIC; (vii) increased
systemic thrombogenesis; and (viii) electrolyte imbalances. Myocardial injury is reported to mainly result from direct viral
involvement of cardiomyocytes and the effects of systemic inflammation. Though venous thromboembolism incidences was
based on a single report, patients with COVID-19 are at increased risk of hypercoagulable states due to prolonged
immobilization, systemic inflammation and risk for DIC.

•

The Cardiac Society of Australia and New Zealand consensus statement on rural and remote cardiology

Heart, Lung and Circulation: The suggested changes in management include: 1) Improved access to telehealth consultation
for regional and rural outpatients. Specialist-led 24/7 ECG reading and acute cardiology services, uniformly covering all rural
inpatients; 2) Transfer models incorporating discussion between clinicians and ambulance, balancing urgency with
considerations of ambulance capacity in rural locations; 3) Protection of the role of specialist cardiovascular nurses, avoiding
COVID-19 redeployment to maintain rural cardiac service capacity; 4) An urgent shift to regional models for pacing services,
utilizing remote monitoring supported by local device implantation and local technicians.

•

COVID-19 Management and Arrhythmia
There is an increased baseline arrhythmia risk in COVID-19 patients which increases further due to infection. The paper
highlights a key role of hERG (or “Kv11.1”) potassium channels in drug-induced arrhythmia risk, in particular, QT interval
prolongation. A list of medications is provided which could be used in the management of COVID-19 which are also
associated with risk of QT prolongation (Propofol, Sevoflurane, macrolides, fluoroquinolones, Fluconazole, Pentamidine,
Lopinavir/ritonavir, Favipiravir, anti-emetics Domperidone, Levomepromazine, Ondansetron, anti-arrhythmics Amiodarone,
Flecainide, Ibutilide, Procainamide, Quinidine, Sotalol, antipsychotics Haloperidol, Quetiapine, Risperidone, Antimalarials such
as Chloroquine, Hydroxychloroquine or Mefloquine).

•

Cardiovascular manifestations and their treatment during COVID-19 pandemic
COVID-19 might directly cause cardiovascular injuries such as pericarditis, myocarditis, myocardial infarction, heart failure,
arrhythmias or thromboembolic events, which urge cardiologists to be involved in the frontline to practice. A review is
provided on cardiovascular system to assist clinical cardiologists to better understand and manage COVID-19.

•

Guidelines on diagnosing and managing COVID-19 related myocarditis
The authors describe COVID-19 related myocarditis clinical findings (changes in ECG, cardiac biomarkers, impaired cardiac
function), recommended diagnostic tests (cardiac MRI, cardiac CT angiography, endomyocardial biopsy), and recommended
management (administration of inotropes and/or vasopressors, mechanical ventilation). The pathophysiology of this
condition is thought to be a combination of direct viral injury and cardiac damage due to the host's immune response.

•

Guidance from the North American Society for reintroduction of cardiovascular services
Specific recommendations are given on the following: STEMI, Acute Coronary Syndrome, Elective Cath Lab Cases,
Transcatheter aortic valve replacement, MitraClip, ASD/PFO, Left atrial appendage closure, Coronary Surgery, Valve Surgery,
other cardiac surgery, Ablation, Device placement, Echocardiography, Cardiac CT, Cardiac MRI, Nuclear Cardiac Imaging,
cardiopulmonary testing, endomyocardial biopsy, R Heart Catheterization, vascular services for critical limb ischemia, aortic
aneurysm Repair, and other vascular issues.

•

Polish updated guidelines on electrotherapy and electrophysiology procedures
Kardiologia Polska: An updated recommendation of Polish experts (Polish Cardiac Society and others) are presented,
including indications and protocols for cardiac electrotherapy and electrophysiology procedures, and the related
organizations arrangements.

•

Long QT in COVID-19 patient treated with HCQ +azithromycin: possible benefits of lidocaine: a case
report
The algorithm is proposed based on a case study of a patient with a QTc of 620 ms with a notched broad T wave following
HCQ+ azithromycin. After 100 mg intravenous lidocaine QTc was 550. The authors developed a flow chart to manage the risk
of QT prolongation and torsades de pointes (TdP) while treating patients in the hospital with combination therapy. Correct K
and Mg, monitor EKG.

•

Canadian Society of Cardiac Surgeons guide on increasing the number of elective cardiac surgeries
The Canadian Society of Cardiac Surgeons provides a template whereby cardiac surgical programs may begin to ramp up the
delivery of cardiac surgery in a deliberate and graded fashion. The safe increase in the number of elective cardiac surgeries is
based on 3 principles: recommendations from public health authorities, proactive management of pre-op patients, and
steadily increasing case volumes to balance clinical needs of patients against overall requirements of the healthcare system.

•

Pediatric and congenital cardiac catheterization during the COVID-19 pandemic

Guidance and recommendations are provided on the preservation and repurposing of resources to help pediatric cardiac
programs develop strategies for patient care during this unprecedented crisis.

•

COVID-19 information for cardiologist: systematic review
A systematic review summarizes the data on COVID-19 useful for cardiologists with the following highlights: 1) Cardiac
manifestations in COVID-19 patients are: myocardial injury, myocarditis, arrhythmia, venous thrombosis and heart failure. 2)
If a patient has shared a room with other patients before being identified as infected with COVID-19, all patients who shared
a room with that person are considered to be isolated for at least 14 days unless SARS-CoV-2 infection is ruled out. 3) In
addition to PPE, it is imperative that devices, including ultra-sound equipment, are cleaned and disinfected. Useful guidelines
are referred to.

•

Chinese Society of Anesthesiology consensus: Anesthetic management of cardiac surgical patients
Patients who undergo cardiovascular surgery necessitate extremely high demands from anesthesia personnel and face high
risks of mortality and morbidity. Anesthesia management guidelines provided for cardiovascular surgery along with the
prevention and control of COVID-19. Guidelines include: preoperative evaluation and prep, anesthetic prep, intraoperative
management, anesthetic management, and postoperative care.

•

Adaptations in outpatient management of structural heart disease
A roadmap for transitioning to telemedicine, and to cancelling and re-prioritizing structural heart procedures is provided.

•

Electrophysiology procedures protocol adaptations implemented for COVID-19
Protocol changes are described for an EP department during the COVID-19 pandemic, including performance of only
urgent/emergent procedures, afterhours/7-day per week laboratory operation, single attending-only cases to preserve PPE,
appropriate use of PPE, telemedicine and video chat follow-up appointments, and daily conferences.

•

Catheterization laboratory priorities during COVID-19: guidelines and recommendations
European Heart Journal offers guidelines on how to manage a catherization lab during the pandemic to complement earlier
guidelines from 1) Journal of the American College of Cardiology; 2) National Institute for Heatlh and Care Excellence.

•

Canadian Society of Cardiac Surgeons guidelines on cardiac surgery
The Canadian Society of Cardiac Surgeons (CSCS) and its Board of Directors have come together to formulate a series of
guiding statements to help to their colleagues on the subjects of leadership, patient triage and risk reduction.

•

Adapting the educational environment for cardiovascular fellows-in-training
The authors discuss strategies to support fellows-in-training in the early stages of the COVID-19 pandemic and the
anticipated challenges as we navigate its course in the United States.

•

STS guidelines on triaging cardiac surgery patients during the COVID-19 pandemic
The guidelines are on behalf of the Society of Thoracic Surgeons (STS) COVID-19 Taskforce and the Workforce for Adult
Cardiac and Vascular Surgery. Guidance provided to the adult cardiac surgery perioperative community regarding
management of patients considered or scheduled for surgical procedures in the context of the current pandemic.

•

Pharmacology of COVID-19 therapies in patients with cardiovascular-related conditions
Cardiovascular risks of various COVID-19 trial therapies are highlighted, as well as their interactions with common drugs for
treating cardiovascular conditions. Several therapies, including remdesivir, hydroxychloroquine and chloroquine, and
interleukin (IL)-6 inhibitors, are being used off-label and evaluated in ongoing clinical trials. These therapies are not familiar
to cardiovascular clinicians managing such patients.

•

US guidelines and priority plan for invasive cardiac electrophysiology procedures
The guidelines were recently published by the HRS COVID‐19 Task Force, the American College of Cardiology (ACC)
Electrophysiology Council, and the American Heart Association (AHA) Electrocardiography and Arrhythmias Committee, to be
found here. The purpose of this manuscript is to provide a priority plan for invasive cardiac electrophysiology procedures
during the COVID‐19 that is consistent with, yet simplified in comparison to, prior recommendation.

•

COVID-19 and cardiac electrophysiology: guidance from a UK tertiary cardiac center

A guide is provided on ablation procedures. In UK catheter ablation procedures that are considered urgent or emergent are:
1)Ablation of ventricular tachycardia that cannot be controlled with medication and leads to hemodynamic compromise,
2)Ablation of an incessant, hemodynamically significant, severely symptomatic tachycardia (SVT/AF/atrial flutter) not
responding to antiarrhythmic drugs, rate control, and/or cardioversion and 3) Ablation for preexcited AF with syncope or
cardiac arrest.

•

Guidance for nuclear cardiology laboratories
American Society of Nuclear Cardiology (ASNC) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) describe
steps for protection of healthcare personnel, inpatients, outpatients, and ED patients.

Clinical Informatics/Research
•

Applied clinical informatics: UW Medicine Information Technology Services experience
Describes rollout of UW Medicine Information Technology Services (ITS) to support clinical response to the pandemic and
provide recommendations for health systems to urgently consider, as they plan their response. Includes dashboards,
communication, HR, telework, telemedicine, EHR changes, tele-ICU. Plus, top-10 list of preparations for health care IT.

•

JAMA viewpoint on clinical research during the COVID-19
The procedures are discussed that would “ensure the rights, safety and wellbeing of participants,” while mitigating risks to
trial integrity. If data are collected during the period of severe disruption in a manner different from the approach originally
planned, the analysis could stratify the data by method of collection. Trialists should present and interpret the results of
clinical trials objectively, explicitly recognizing both the strengths of the analyses and the uncertainties resulting from the
pandemic.

Dentistry
•

Guidelines overview for dental care settings
A review of several dentistry guidelines is provided. There is universal concurrence on directives such as postponing elective
dental treatment, developing appropriate screening protocols through telecommunication, applying special additional
droplet precautions when treating patients with dental emergencies, and sequestrated treatment of infected /suspected
patients in specially fitted suites with negative pressure. The recommended equipment and settings are described for clinics
that can receive confirmed COVID-19 patients. The authors provide an overview of the dentistry practice in the postpandemic era, as well as potential developments in antiviral drugs and vaccines.

•

Orthodontic management during the COVID-19 pandemic
A comprehensive summary is provided with suggestions such as suspending elective treatment as well as contingency plans
in case of emergency and for day to day practice. There is also a discussion of viral transmission in the context of orthodontic
procedures.

•

Scottish Dental Clinical Effectiveness Program: COVID-19 guidance update
The Scottish Dental Clinical Effectiveness Program (SDCEP) has now modified its guidance on management of commonly
presenting oral conditions for use during the COVID-19 pandemic. The new 'Management of Acute Dental Problems during
COVID-19 Pandemic' guide is available now on the SDCEP website: http://www.sdcep.org.uk/.

Dermatology
•

Algorithm for classification of COVID-19 rashes
Up to a 20% of COVID-19 patients have skin manifestations such as erythematous rash, petechiae, vesicles, acral ischemia,
livedo reticularis, and widespread urticaria. When examining patients with generalized exanthem from COVID-19, the first
step is to look for the presence of vesicles or secondary erosions with crusts. If absent, a blanching component can be
assessed by pressing the affected area for several seconds. Non-blanching generalized rashes composed of small red macules
are indicative of a rash with petechiae. An acral distribution of non-blanching violaceus lesions is indicative of acral ischemia.

A reticulated vascular pattern indicates livedo reticularis. For blanching rashes, the next step is to scratch the skin.
Dermographism would manifest as linear wheals at sites of scratching and indicate urticarial rash while its absence indicates
erythematous rash. A flashlight photo after each step may be taken.

•

Minimal contact strategy for dermatology clinical operations
Use work scheduling to limit patient contacts and healthcare worker exposures.

•

Withold dermatological immunomodulators for suspected/confirmed cases
Australia/New Zealand consensus statement. In patients with suspected or confirmed COVID-19 disease, all
immunomodulators used for skin diseases should be immediately withheld, with the possible exception of systemic
corticosteroid therapy, which needs to be weaned. In patients who develop symptoms or signs of an upper respiratory tract
infection, but COVID-19 is not yet confirmed, consider dose reduction or temporarily cessation for 1-2 weeks. In otherwise
well patients, immunomodulators and biologics should be continued.

•

Recommendations on dermatologic surgery during the COVID-19 pandemic
Where possible, clinics should be triaged so that only urgent patients are reviewed in person, with telehealth employed
where appropriate. Elective surgery such as excision of benign lesions and cosmetic procedures should be postponed. This
and other recommendations regarding dermatological surgery during COVID-19 pandemic are provided.

•

Chinese recommendations on burns management during COVID-19 pandemics
The recommendations suggest outpatient treatment of burned patients over inpatient, as well as the use of telemedicine.
Non-urgent surgery should be suspended. Try to accomplish wound surgery as briskly as possible.

Diabetes
•

Managing type 2 diabetes mellitus during COVID-19 pandemic
Diabetes Metabolism: Type 2 diabetes mellitus (T2DM) is a risk factor for worse prognosis in patients with COVID-19.
Continuing agents such as SGLT2 inhibitors or GLP1RA in T2DM patients with COVID-19 is reasonable due to their established
cardiorenal protective effects, in addition to potential anti-inflammatory effects, yet maintaining hydration and frequent
blood glucose monitoring is advised. DPP4 inhibitors also represent an appropriate choice, especially for patients who are
prone to hypoglycemia and do not tolerate SGLT2 inhibitors and/or GLP1RA. In those with COVID-19 and admitted to the
hospital, intravenous insulin remains the drug of choice, while discontinuation of oral agents should be considered. Of note,
DPP4 inhibitors remain safe and potentially have a protective role, therefore its continuation may not be necessary.

Disaster Medicine
•

Evacuating individuals flown to the airport who needs to be quarantined: experience of Taiwan
After the lockdown of Wuhan and Hubei, the Taiwanese government planned to evacuate its citizens by means of chartered
flights. A detailed evacuation workflow is described to minimize the possibility of surface environmental contamination.

Emergency Medicine
•

Emergency department triage tool for identifying patients requiring isolation
MedRxiv preprint: A novel system of patients triaging was implemented at the University College London Hospital. All
admitted patients were allocated to one of 4 categories: (A) - low likelihood of COVID-19 but significant comorbidities – they
were given the highest priority for single-occupancy rooms; (B and C) - high probability of COVID-19, with category B having
significant comorbidities. Category B patients were second priority for single-occupancy rooms. When such rooms were
unavailable these patients were cohorted in reduced occupancy multi-bedded bays on wards designated for suspected
COVID-19 patients; (C) -minimal comorbidities –cohorted in the same reduced occupancy multi-bedded bays with other
category C or B patients; (D)- low probability of COVID-19 and no significant comorbidities - cohorted together on the same
ward as suspected COVID-19 patients.

•

Recommendations for emergency departments receiving patients in cardiac arrest

The Canadian Journal of Emergency Medicine published recommendations to enhance staff and patient safety during COVID19 by discussing the risk of transmission during certain aerosol generating procedures and suggesting measures for reducing
unnecessary exposure for ED staff, paramedics and other ED patients when receiving patients in cardiac arrest.

•

Coronavirus Disease (COVID-19): A primer for emergency physicians
AJEM review article provides emergency physicians with recommendations on the evaluation and management of patients
with suspected COVID-19.

•

A consensus for non-ICU ARF SARS-CoV-2 emergency in Italy
Italian respiratory scientific societies propose an early consensus statement for emergency management of non-ICU ARF
SARS-CoV-2. It represents the expert opinion of pulmonologists directly involved in the first line of assistance. The Consensus
identified two urgent areas for action: a) management, and b) organization.

•

Cardiopulmonary resuscitation guidelines issued
Interim guidance issued for adults, children and neonates that will reduce provider exposure and prioritize oxygenation and
ventilation strategies with lower aerosolization risk. Providers should consider the appropriateness of starting and continuing
resuscitation.

•

An emergency amendment to the National Scope of Practice for Paramedics are needed
Changes to paramedic scopes of practice related to airway and ventilator management are urgently needed across rural
America, where existing limited resources are challenged for the coming months. Changes to paramedic scopes of practice
need to be supported through local regulatory changes, access to education and mentoring, consideration of health
professional and patient safety, and ongoing monitoring of these and other emerging issues.

•

A summary for paramedics on COVID-19
An author's summary provides guidance to paramedics on best approach to COVID-19 patients in the prehospital settings.

•

Emergency management of nursing human resources and supplies: Wuhan hospital example
The Nursing Department of the Wuhan hospital fully executed its functional authority to establish a three-level echelon of
sustainable support, allocate human recourses dynamically, organize pre-service training, supervise the key working steps,
formulate positive incentive methods, and deploy medical supplies scientifically. By taking these strategies, the hospital
effectively improved the coping capacity of the nursing team and contributed to prevention and treatment of COVID-19.

•

ESTES recommendations for trauma and emergency surgery preparation
European Society of Trauma and Emergency Surgery's recommendations regarding hospital perioperative preparation for
COVID-19: (1) General recommendation for surgical services; (2) Emergency Surgery for critically ill COVID-19 positive or
suspected patients -Preoperative planning and case selection; (3) Operating Room setup; (4) patient transport to the OR; (5)
Surgical staff preparation; (6) Anesthesia considerations; (7) Surgical approach; and (8) Case Completion. The European
Society of Emergency Surgery board endorsed these recommendations.

•

SARS-CoV-2: an overview for emergency clinicians
A review analyzes information from worldwide research and experience on the epidemiology, prevention, and treatment of
COVID-19, and offers links to the most reliable and trustworthy resources to help equip healthcare professionals in managing
this public health challenge.

•

Managing neonatal ICU during COVID-19: Italy experience
The authors share their experience of dealing with COVID‐19 outbreak in Padua, where the epidemic is ongoing and rapidly
evolving, to promote debate on the preventive measures to adopt in NICUs. The approach is discussed to patient triage,
nasopharyngeal swabs, preventive measures and maternity issues.

•

Personal and protective equipment in emergency oro/nasopharyngeal conditions: UK guidelines
New personal and protective equipment guidance from the British Association of Oral and Maxillofacial Surgeons (BAOMS)
and ENT UK advises surgeons on how to treat patients with emergency oropharyngeal and nasopharyngeal conditions. For

full information about the new guidance go to BAOMS: www.baoms.org.uk; ENT UK: www.entuk.org and BAOS:
www.baos.org.uk.

•

Novel COVID-19 ICU care team models in New York
New York-Presbyterian, in partnership with Weill Cornell Medicine and Columbia University Vagelos College of Physicians and
Surgeons, has redeployed physician teams to over 550 incremental ICU beds, structured around a supervised pyramidstaffing model. They supported these new teams by reimagining care models, utilizing e-consultation (e.g., e-ICU), and
extending palliative care. Lessons learned include the need to maintain flexibility, off-load tasks to novel team members, and
embrace the use of technology.

Endocrinology
•

Management of obesity and metabolic syndrome during COVID-19 pandemic
COVID-19 patients with obesity and other comorbidities including metabolic syndrome are at a higher risk of requiring ICU
stay and have increased rates of mortality. The authors outline the impact of COVID-19 on obesity and its associated
metabolic syndrome, and the measures that can be taken to ensure that patients continue to receive adequate care during
this pandemic. Pre-bariatric management includes education on healthy eating and exercise. Close follow-ups by
multidisciplinary teams are essential for post-bariatric management. Authors recommend using online and telephonic
platforms for these important communications to ensure best care.

•

Management of adrenal insufficiency during COVID-19 pandemic
UK authors highlight the need for education (sick day rules, stringent social distancing rules), equipment (sufficient
glucocorticoid supplies, steroid emergency self-injection kit) and empowerment (steroid emergency card, COVID-19
guidelines) to prevent adrenal crises. In patients with adrenal insufficiency developing an acute COVID-19, which frequently
presents with continuous high fever, they suggest oral stress dose cover with 20mg hydrocortisone every six hours. They also
comment on suggested dosing for patients who usually take modified release hydrocortisone or prednisolone. In patients
showing clinical deterioration during an acute COVID-19, they advise immediate (self-)injection of 100mg hydrocortisone
intramuscularly, followed by continuous intravenous infusion of 200mg hydrocortisone per 24 hours, or until this can be
established, administration of 50mg hydrocortisone every 6 hours.

•

Diabetic retinopathy screening during the COVID-19: Hong Kong experience
The Hong Kong clinical departments adopted the following measures for managing diabetic retinopathy screening: 1)
Screening of all visitors for: fever, history of respiratory symptoms, recent overseas travel, and contact/exposure to COVID-19
cases; 2) Universal face-covering with surgical or N95 masks by staff and all visitors; 3) Protective plastic shields installed on
all slit lamps, which are used during eye examinations; 4) Reduced number of scheduled visits.

•

Glycemic control in diabetic patients during COVID-19 outbreak
In this short narrative, Indian authors highlight the biochemical properties of common anti-diabetic drugs related to SARSCoV-2. They emphasize that good glycemic control is optimal for boosting innate immune system. They also note that
hydroxychloroquine (HCQ) is approved by the Drug Controller General of India as a third-line add-on anti-diabetic drug and
may be a good adjunctive treatment during this outbreak for patients with poor glucose control. Check diabetic retinopathy
and cardiomyopathy prior to recommending HCQ. In response to this paper here the other authors convey additional
information and concerns regarding COVID-related anti-diabetic drugs. In particular, they note that Metformin increases
lactate production, which is already increased in COVID-19, thus, it may not be safe. Authors endorse insulin plus
dapagliflozin combination as the best treatment option for patients with COVID-19 infection.

•

COVID-19 and endocrine diseases: statement of the European Society of Endocrinology
Recommendations: 1) Adequately protect yourself and ask for COVID-19 testing if exposed; 2) Avoid unnecessary routine
appointments in person; 3) Put in place online/email/phone consultation services; 4) Closely monitor glycemic control in
patients with diabetes; 5) Recommend to persons with diabetes a strict adherence to general preventive measures; 6)
Counsel persons with diabetes about specific measures related to their disease management in case of infection; 7) Counsel
persons with diabetes particularly if aged over 65 and obese about referrals for management in case of suspected infection;

8) Avoid undernourishment with dietary or adjunctive measures if clinically indicated; 9) Closely monitor clinical condition of
patients with adrenal insufficiency; 10) Adapt increased replacement treatment in patients with adrenal insufficiency.

•

COVID-19 and glucocorticoids in adrenal insufficiency: update from the Italian Society of Endocrinology
For adrenal insufficiency (AI) patients suspected to have COVID-19, who have mild upper respiratory tract symptoms and no
lung impairment, doubling the usual dose of hydrocortisone (alongside adequate fluid replacement) in a circadian fashion
seems a safe measure to preserve the early activation of the immune response. The latter is also because symptoms are not
specific and may last, even if minor, for 2 weeks or more. As soon as symptoms worsen, it is advisable to further increase the
dose up to 100 mg, commence thromboembolic prophylaxis and consider prompt hospitalization as the condition could
deteriorate within few hours. In hospital, parenteral treatment with high doses (200 mg) of continuous intravenous
hydrocortisone is only required following evolution towards a critical stage (rapid drop in oxygenation) or adrenal crisis.

•

Management of pituitary tumors during COVID-19
Recommendations are provided by a group of international researchers. Face to face visits for patients with pituitary tumors
could be postponed in most cases for 3-6 months without compromising optimal care. Endocrine help-line run by
endocrinologists and endocrine nurses should be available 24/7 aiming to offer immediate support to patients with urgent
problems/queries, to reduce anxiety and to reduce workload of primary care clinicians. Dissemination of websites of patient
support groups is strongly recommended.

Endoscopy
•

Guidelines to manage an endoscopy unit during pandemic
A video (available online atwww.VideoGIE.org/) shows how to manage an endoscopy unit during the COVID-19 pandemic,
with specific details on workflow, screening of staff, screening of patients, management in pre-procedure areas and
endoscopy rooms, postprocedural management, environment disinfection, endoscopy disinfection, and patient follow-up.
The authors also provide details on how to put on and remove personal protective equipment.

•

Endoscopy units: A multi-center experience from Italy
A survey investigated the burden of COVID-19 on endoscopic activity in a high-risk area, approaches to evaluating patients,
adoption and compliance of HCP with protective measures, and initial possible viral transmission outcomes from endoscopy
units within a large, community-based setting in Italy.

Gastroenterology
•

French recommendations for IBD endoscopy during COVID-19 pandemic
Nature reviews gastroenterology and hepatology: Société Française d'Endoscopie Digestive provides its recommendations.
Measures of prevention should be planned and adopted in all endoscopy units that manage patients with and without
inflammatory bowel diseases (IBD). In the management of IBD- specific endoscopic situations, alternative biomarkers
replacing non-urgent endoscopy, such as fecal calprotectin home test to assess disease activity, should be considered and
implemented. To understand whether endoscopy could be rescheduled, it is important to maintain close contact with
patients by phone or e-mail to monitor for specific symptoms (through the use of standardized questionnaires) and general
clinical condition as well as for indications of SARS- CoV-2 infection.

•

The Gobal guidance for inflammatory bowel disease treatment research trials
Journal of Crohn's and Colitis: The authors suggest 10 rules to guide patients and researchers in continuing the necessary
work on IBD: (1) continue trials as long as safety for patient and research site are secured (2) consider recruiting those who
lack therapeutic alternatives (3) patients positive for COVID-19 should not be enrolled but should have standard therapy (4)
keep low corticosteroid exposure (5) avoid minimizing duration of immunosuppression during trial (6) avoid unblinding
patients unless safety is of concern (7) decrease patient exposure to COIVD-19 with telemonitoring (8) allow time window
changes (9) document emergent COVID-19 related changes (10) resume standard therapy if a participant withdraws.

•

Asian guidelines on IBD management during the COVID-19 pandemic

The experts of the Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) put
recommendations based on their experience and the currently available data. In general, most IBD therapies (with a few
exceptions) can be continued safely, and the general consensus is that maintaining disease control should remain the main
principle of management. Social distancing measures and the appropriate use of PPE should be strictly adhered to. Face-toface clinic follow ups and non-urgent procedures should be kept to a minimum.

•

Indian Association of Gastrointestinal Endo Surgeons COVID-19 endoscopy recommendations
Journal of Minimal Access Surgery: Recommendations from the Indian Association of Gastrointestinal Endo Surgeons for safe
performance of diagnostic and therapeutic endoscopy during the COVID-19 pandemic are published. Stop all elective
endoscopy (perform only in urgent and emergency cases). Stop seeing and reviewing non-urgent cases. Strict use of PPE and
social distancing. Perform RT-PCR prior to endoscopy. Fill out a comprehensive informed consent form. Use high-level tools
disinfection. Follow up all patients who underwent endoscopy for 2 weeks.

•

Gastroenterology department in Ganzgzhou reopens to full capacity without nosocomial infection
A gastroenterology department gradually resumed full outpatient operations without nosocomial cases, as of April 24th, by
screening all patients by symptoms, rtPCR, and chest CT. Patients were scheduled 30 minutes apart and were asked to keep 1
meter distance between themselves and others. Inpatient visitors were allowed with negative rtPCR and patients who
developed a fever while admitted were retested with rtPCR. As of April 24th, inpatient census is at 50% pre-pandemic levels.

•

Managing Inflammatory Bowel Disease: recommendations of gastrointestinal societies
A review of guidelines showed that all societies recommend continuing IBD-specific treatment as risk of active disease is
perceived to be higher than the uncertain risks of immunosuppression predisposing to COVID-19. Minimizing corticosteroid
exposure by rapid tapering whenever possible is universally recommended, with some societies additionally suggesting
topical corticosteroids or exclusive enteral nutrition as alternatives for patients experiencing a flare. Thiopurine initiation is
discouraged due to increased risk of viral infection and need for concomitant induction corticosteroid. Caution is needed
with initiating combination therapy. Some societies suggest stopping thiopurine treatment in patients ≥ 65 years and those
with significant comorbidities in stable remission. For patients commencing biological therapy, subcutaneously administered
drug may be preferred based on local circumstances to maximize social distancing efforts. Forced switching to subcutaneous
biologics should only be used in centers unable to provide infusions. There are no data to favor one class of biologics over
another in the context of COVID-19.

•

Indian guidelines for gastroenterologists on prevention and management of COVID-19
Tree Indian GI professional bodies (Society of Gastrointestinal Endoscopy of India (SGEI), Indian Society of Gastroenterology
(ISG), and Indian National Association for the Study of the Liver (INASL) provide their guidance for gastroenterologists and GI
endoscopists.

•

Updated review of GI endoscopy guidelines for procedures, PPE use, etc.
All national and international societies recommend the use of gloves, mask, goggles/face shield, gown, and hairnet during all
procedures. N95 or FFP2/3 masks and double gloves were recommended in suspected or confirmed cases. All societies
recommend following current standardized reprocessing procedures for equipment. Nearly all societies recommend
postponing elective and non-urgent procedures. Most societies recommend screening patients for symptoms prior to
procedure. Other recommendations include training for PPE donning and removing and self-surveillance of signs/symptoms
by health care workers.

•

Inflammatory Bowel Disease surgery: international recommendations
International Organization for the Study of Inflammatory Bowel Disease provides recommendations for surgery in patients
with IBS. Ulcerative colitis patients with high-grade and low-grade dysplasia may be delayed in the short-term, but special
attention should be considered by the multidisciplinary tumor board since the risk of synchronous cancer at immediate
colectomy can be up to 42% and 19% respectively. Invasive colon and rectal cancer in the setting of asymptomatic or mild
symptomatic ulcerative colitis, should be treated as a non-elective procedure, considering patients symptoms, and
metastatic workup. There is no contraindication for the use of minimally invasive surgery for COVID-19 patients, but risks and

benefits must be discussed with the operative team. The liberal use of temporary fecal diversion is suggested to minimize the
risk of septic complications because overwhelmed hospital systems likely have a diminished capacity to rescue ill patients.

•

The preventive strategies for GI physicians during COVID-19: experience of Iran clinic
The authors describe preventive strategies that may significantly reduce the close contact between patients and
gastrointestinal (GI) physicians. These measures were implemented in one Iran's hospital after a 20% increase in the number
of referred COVID-19 patients with unusual GI symptoms, forcing an intensive diagnostic.

•

Gastroenterology department reorganisation during COVID-19
This proposal is based on Italian and Chinese experience.

•

Management of inflammatory bowel disease during Covid-19 pandemic
The British Society of Gastroenterology COVID-19 Inflammatory Bowel Disease (IBD) Working Group has generated a risk grid
that groups patients into highest, moderate and lowest risk categories for management of IBD. Further, consideration is
given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials.

•

Endoscopy in inflammatory bowel disease during and after COVID-19 pandemic
The Lancet reports: The authors highlight different scenarios in which endoscopy should still be performed urgently in
patients with IBD, as well as recommendations regarding the use of PPE. They suggest a pathway for performing safe
endoscopy and discuss the potential risks of postponing endoscopy in IBD. Also, they propose a post-pandemic plan for
access to endoscopy.

•

Resumption of activity in gastroenterology department: Spanish recommendations
A number of practical recommendations are provided by Spanish organizations (SEPD, AEEH, GETECCU and AEG) regarding GI
patient management and the stepwise resumption of GI healthcare activity. These recommendations are based on the
sparse, changing evidence available, and will be updated in the future.

•

Guidelines on management of IBD patients during the COVID-19 pandemic
Here, the World Endoscopy Organisation (WEO) is providing practical advice for the management of inflammatory bowel
disease (IBD) patients during the pandemic covering the diagnostic and therapeutic aspects.

•

European Hernia Society guidelines for hernia management during COVID-19
The European Hernia Society published recommendations on abdominal wall surgery including managing emergency cases,
elective surgery, and triage measures. Some of the principles of abdominal wall surgery were clarified a result of recent
criticism (mesh, minimally invasive surgery) and adaptation of technique (midline restoration) to minimize raising intraabdominal pressure. In the absence of suspected strangulated tissue in the hernia, the use of taxis (manual reduction of the
incarcerated hernia) under sedation/analgesia followed by observation may allow surgery to be safely delayed for a number
of weeks. There is no evidence for contraindication of the laparoscopic approach. There is little-to-no evidence of infection
via blood transmission or as a consequence of a pneumoperitoneum per se from patient to healthcare worker. The
desufflation of any gas from the pneumoperitoneum through a virus filter is recommended. Trocar wounds should be kept at
minimum length to avoid air leaks around the port. In the case of open-access trocars, the use of ports with retention balloon
should be considered to minimize inadvertent removal of the port. COVID-19 is found in the stool of a proportion of patients,
thus, in any surgery in which the bowel is opened, regardless whether laparo/endoscopic or open, care should be taken
because of the presumed risk of virus exposure from the intestinal content.

General Internal Medicine, Outpatient and Ambulatory
•

CDC's Interim Additional Guidance for Outpatient and Ambulatory Care Settings
The guidelines include: Key Considerations for Healthcare Facilities, Actions to Take in Response to Community Transmission
of COVID-19, and Other Considerations for Ambulatory Care Settings.

Geriatrics
•

American Geriatrics Society policy recommendations for public health planning, etc.
AGS recommends the Defense Production Act include nursing homes (NH), congregate living settings, and home health care
in estimates for PPE response. All COVID-19 positive patients should only be discharged to NH if the transfer can be
performed in accordance with CDC guidelines. CDC should develop guidance regarding transfers to ED for residents
presumed or confirmed to have COVID-19. Geriatric health professionals and hospice/palliative care experts should be
included in emergency planning and response teams. Consider using "hospital-at-home" models of care where possible.
More recommendations in the policy brief can be found in the link.

Hematology and Oncology
•

Patient blood management during COVID-19 pandemic
A meta-analysis revealed that the implementation of Patient Blood Management (PBM) leads to an overall decrease in
transfusion demand by 39% and results in reduced morbidity, namely 25% reduce in acute renal failure and thrombotic
events. PBM is an evidence-based multimodal approach based on three main pillars: diagnosis and treatment of anemia,
minimizing (iatrogenic) blood loss, rationale use of blood units. Its most important components are: Preoperative intravenous
iron substitution; Intraoperative tranexamic acid; Maintaining physiological conditions: normothermia, pH > 7.2, Calcium >
1.1 mmol/L; Cell salvage and re-transfusion of processed blood; Single-unit policy (reassessment after each blood unit);
Rational numbers of diagnostic blood samples; Non-invasive hemoglobin measurement; Correction of coagulation anomalies
ASAP.

•

Australia and New Zealand guidelines on managing hematology and oncology patients
In patients with cancer with fever and/or respiratory symptoms, consider causes in addition to COVID-19, including other
infections and therapy-related pneumonitis. For suspected or confirmed COVID-19, discuss temporary cessation of cancer
therapy with a relevant specialist. Provide information on COVID-19 for patients and caregivers. Adopt measures within
cancer centers to reduce risk of nosocomial SARS-CoV-2 acquisition; support population-wide social distancing; reduce
demand on acute services; ensure adequate staffing; and provide culturally safe care. Consider the risks and benefits of
modifying cancer therapies due to COVID-19. Communicate treatment modifications, and review once health service capacity
allows. Consider potential impacts of COVID-19 on the blood supply and availability of stem cell donors. Discuss and
document goals of care and involve palliative care services in contingency planning.

•

Australian and New Zealand guidelines on management of hematologic malignancies
A consensus between authors from Australia and New Zealand recommends that patients should be informed of their
vulnerability to COVID‐19. Use telemedicine and non‐hospital pathology services, change i.v. preparations to subcutaneous,
and use direct‐to‐home delivery of oral medications. The informed consent process for chemotherapy should include
documenting a discussion about the risks of COVID‐19 and strategies to avoid infection, as well as the potential risks of
reduced hospital capacity to deliver on‐time chemotherapy and routine supportive care. If infected with COVID‐19 during
chemotherapy, the decision to continue or re‐initiate chemotherapy needs to be made on a case‐by‐case basis. Specific
recommendations are given on managing each individual type of malignancy.

•

UK challenges of managing hematology patients during COVID-19 pandemic
Oxford researchers note that there has been a 71% fall in the numbers of full blood counts performed from primary care in
the four weeks since the lockdown was introduced, 57% fewer patients referred to hematologists, and dramatic decrease of
chemotherapy treatments. It is likely that as the first wave of COVID-19 recedes, there will be a corresponding rise in demand
on hematology clinics, day units and wards to deliver care not only for the anticipated increased numbers of new patients,
but also to restart deferred treatments for existing patients. The longer the lockdown is imposed, the greater the rebound
surge might be expected to be.

•

Seattle Cancer Center guidelines on managing hematologic malignancy and COVID-19

Specific guidelines are posted for Non-Hodgkins Lymphoma (NHL), Early Diffuse Large B-Cell Lyphoma (DBCL), Relapsed
DLBCL, untreated and relapsed Hodgkin Lymphoma in older and younger patients, Chronic Lymphocytic Leukemia, Peripheral
T-Cell Lymphoma, new and relapsed indolent B-Cell NHL, new and relapsed Mantle Cell Lymphoma, Acute Myeloid Leukemia,
Myeloproliferative Neoplasms, Myelodysplatic Syndrome, Ph+ and Ph - Acute Lymphoid Leukemia, and Multiple Myeloma.

•

Hematopoietic cell transplantation and cellular therapy: ASTCT statement
The American Society for Transplantation and Cellular Therapy (ASTCT) Pharmacy Special Interest Group (SIG) Steering
Committee provides this position statement for pharmacy practice management and clinical management recommendations
for COVID-19 in HCT and cellular therapy recipients.

•

Expert recommendations on blood purification treatment in COVID-19
A protocol was developed by Chinese researchers including four steps: 1) assess whether patients with severe COVID-19
require blood purification. 2)prescribe a blood purification treatment; 3) monitor and adjust parameters of blood
purification; 4) evaluate the timing of discontinuation of blood purification.

•

International guidelines for hematopoietic stem cell transplantation
The guidelines were issued by the European Society for Blood and Marrow Transplantation (EBMT) and American Society for
Transplantation and Cellular Therapy (ASTCT). They include a negative COVID-19 PCR test prior to transplant as well as
completing 14 days of isolation before starting transplant conditioning. Donors who test positive for COVID-19, who are
symptomatic, or who have traveled to high risk areas should defer to donate unless the case is urgent and there are no
alternative donors. As of March 20,2020, 15 cases of COVID-19 cases in post-hematopoietic stem cell transplantation setting
(15 allogenic and 3 autologous) have been reported from Europe with one death.

Hepatology
•

Liver associations recommendations for hepatology and liver transplant care
Clinical Liver Disease: All associations recommend reducing patient visits and a delay in hepatocellular carcinoma (HCC)
ultrasound surveillance. American Association for the Study of Liver Disease (AASLD) recommends HCC treatments should
proceed. European Association for the Study of the Liver (EASL) recommends locoregional therapies should be postponed
whenever possible and immune-checkpoint inhibitor therapy be temporarily withdrawn. Tyrosine kinase inhibitors (TKI) in
non-severe COVID-19 should be taken on a case-by-case basis. Asian Pacific Association for the Study of the Liver (APASL)
recommends postponing elective transplant/resection surgery, whereas radiofrequency ablation, transcatheter arterial
chemoembolization, TKI, or immunotherapy can be initiated with change of immunotherapy schedules to every 4 to 6 weeks.
AASLD recommends against liver transplantation (LT) in patients with COVID-19. LT can proceed 21 days after symptom
resolution and negative diagnostic tests in recipients. APASL suggests balancing risks of delaying LT against risks of
transmission to health care workers. APASL recommends LT be performed only in patients with COVID-19 with at least two
consecutive negative SARS-CoV-2 nucleic acid results and the presence of antibodies. There is debate whether immunosuppression should be reduced during the COVID-19 pandemic. All of the guidance suggests that the underlying cause of liver
injury may be related to SARS-CoV-2, exacerbation of preexisting chronic liver disease, or drug-induced hepatotoxicity.

•

Management of patients after liver transplantation
The authors reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients,
immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver
transplant recipients during the COVID-19 epidemic.

•

Management of patients with autoimmune liver disease during COVID-19 pandemia
A brief description of the management protocol is presented which is developed and implemented for patients with AILD in
three referral centers in Europe during the present pandemic.

•

Management of liver disease during the COVID-19
European Association for the Study of the Liver (EASL) and the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) issued a position paper, providing recommendations for clinicians caring for patients with liver diseases
during the current pandemic.

Hospital Medicine and Intensive Care
•

Early management proposal calls for helmet continuous positive airway pressure and prone positioning
Italian researchers hypothesize that selected COVID-19 patients may benefit from a combination of early helmet continuous
positive airway pressure (hCPAP) and prone position sessions, which may reduce the need for intubation and invasive
mechanical ventilation, shorten the hospital length of stay, and improve survival rates. Furthermore, the need for ICU beds
may be reduced, in favor of sub-tensive beds.

•

Computational models to use for predicting respiratory decompensation in hospitalized patients
In this observational, retrospective cohort study on ER adult patients with COVID-19, two predictive models were developed
using patient demographic and clinical data collected from 8 hospitals (N=932): a quick COVID-19 severity index (qCSI) model
that uses only exam and vital sign measurements, and a COVID-19 severity index (CSI) machine learning model. The qCSI
model (AU-ROC: 0.90) comprised of nasal cannula flow rate, respiratory rate, and minimum documented pulse oximetry
outperformed the baseline models (illness scoring systems qSOFA: 0.76; Elixhauser: 0.70; CURB-65: AU-ROC 0.66) and was
validated on an external cohort (AU-ROC: 0.82). The machine learning-based CSI had superior performance on the training
cohort (AU-ROC: 0.91) but was unlikely to provide practical improvements in clinical settings. The qCSI tool is available at
covidseverityindex.org.

•

Intensive care recommendations: collaboration enhances survival of critically ill patients
The pandemic associated challenges include rapid diagnosis and isolation, clinical management and prevention for both
COVID-19 and other patients. ICU stakeholders must prepare for increase in critical care bed capacity. Inadequate ICU
resources will require critical care triage. Collaboration at the local, regional, national, and international level offers the best
chance of survival for the critically ill.

•

High prevalence of venous thromboembolism (VTE) -- high D-dimer predicts bad outcomes
Incidence of VTE in severe pneumonia COVID-19 patients was 25% (20/81), of which 8 patients with VTE events died. VTE
group was different from non‐VTE group in age, lymphocytes count, activated partial thromboplastin time (APTT), D‐dimer.
D-dimer cut-off of >1.5 µg/mL predicted VTE with sensitivity of 85.0%, and specificity of 88.5%, and negative predictive value
(NPV) of 94.7%.

•

Swiss consensus on thromboprophylaxis and lab monitoring for inpatients with Covid-19
Based on the available literature and published recommendations from the International Society of Thrombosis and
Hemostasis and from the Society for Thrombosis and Haemostasis Research, the Working Party on Hemostasis proposes the
recommendations for pharmacological thromboprophylaxis in COVID-19 patients in the acute setting.

•

Nutrition support protocol proposed by Italian experts
A pragmatic protocol for the delivery of nutrition therapy in pre-ICU patients with COVID-19 is published. Protocol was
devised by a multidisciplinary team of experts working in Lombardy, Italy, which is the center of the Italian COVID-19 crisis.

•

ESPEN guidance for nutritional management of individuals with SARS-CoV-2
European Society for Clinical Nutrition and Metabolism (ESPEN) provides guidance for nutritional management of COVID-19
patients by proposing 10 practical recommendations. The guidance is focused to those in the ICU or in the presence of older
age and polymorbidity, which are independently associated with malnutrition.

•

Long Island hospital's rapid innovation: "forward triage"
The hospital opened an incident command center. They created a 16-bed “forward triage” and treatment unit for ED patients
in an ambulatory care center off site to expedite the care of persons under investigation with less acute illness. Physicians
and nurses were rapidly retrained and reassigned according to need. A hospital-wide registry of persons under investigation
for COVID-19 was established. 70% of patients seen in the ED were sent home. Of the 30% admitted, ~10% required
immediate intensive care or mechanical ventilation, and 15% required these resources within 2 days after admission.

•

German recommendations on critically ill patients with COVID-19

The recommendations provide the guidance to physicians treating COVID-19 patients in ICUs. Apart from specific
recommendations, a need for multidisciplinary approach is emphasized involving infectious disease and infection control
specialists on the team.

•

Infection in psychiatric hospitals during COVID-19: mistakes and recommendations
It is suspected that once the nosocomial infections started to occur, neither Chinese nor Korean psychiatric wards were able
to respond rapidly. The authors compare the mistakes occurred in both clinical settings and give the appropriate
recommendations to prevent them.

•

Managing COVID-19 (including at the end of life) in the community: NICE guidelines
The National Institute for Health and Care Excellence (NICE) in collaboration with NHS England and NHS Improvement
provide guidelines: 1) Put treatment escalation plans in place for patients with COVID-19 because they may deteriorate
rapidly and need urgent hospital admission. 2) Encourage patients with cough to avoid lying on their back and, for those with
a cough that is distressing, to consider short term use of codeine linctus, codeine phosphate tablets, or morphine sulfate oral
solution. 3) Use controlled breathing techniques such as positioning, pursed-lip breathing, breathing exercises, and
coordinated breathing training.

•

Quantitative CT can be used for assessment of pneumonia severity on admission
A quantitative method based on multi-scale convolutional neural networks was used to assess the infected lung segments. It
was also compared with the semi-quantitative method, and Spearman correlation (rs) was explored with lab test parameters
and pneumonia severity index (PSI). The proportion of “ground glass opacity” based on the quantitative method positively
correlated with the semi-quantitative CT score (P < 0.001 for all; rs = 0.88, 0.87, 0.90), lung consolidation on quantitative
method correlated with C-reactive protein levels (P = 0.0278, 0.0168, 0.0078; rs = 0.40, 0.43, 0.48), and total lung lesion
(quantitative method) correlated with erythrocyte sedimentation rate (P = 0.0296, 0.0408, 0.0048; rs = 0.46, 0.44, 0.58).
These quantitative findings were also negatively correlated with the lymphocyte count (P = 0.0222, 0.0024, 0.0068; rs = 0.42, -0.53, -0.48).

•

Care map and low PEEP reduce ventilation days, ICU admission, mortality and LOS
In a retrospective analysis of clinical data on patients with COVID-19 pneumonia and ARSD admitted to ICU an increased
survival was observed in patients with low positive end-expiratory pressure (PEEP) compared to other groups. A possible
explanation could be that the relative low-pressure ventilation avoids transforming an initial alveolitis into an ARDS-iatrogenic
framework, in which the local ongoing inflammation is rather damaged than helped by high PEEP (generating a VentilationInduced-Lung Injury - VILI) in a context that is the “not-classic” ARDS. The authors also recommend their multimodal program
(“care map”) which implements Early Warning Score (EWS) monitoring for intermediate care patients, in order to perform a
strict selection of ICU admission and employ mechanical ventilation as little as necessary. This program allowed to reduce the
number of ICU admissions, the number of ventilation days and mortality.

Infectious Disease
•

Infectious Diseases Society of America guidelines on management of patients with COVID-19
Recommendations on inpatients with COVID-19: 1) HCQ/chloroquine in the context of a clinical trial; 2) HCQ/chloroquine
+azithromycin only in the context of a clinical trial; 3) combination of lopinavir/ritonavir only in the context of a clinical trial.
4) corticosteroids in pneumonia cases (conditional recommendation, very low certainty of evidence); 5) with ARDS the use of
corticosteroids in the context of a clinical trial; 6) tocilizumab only in the context of a clinical trial; 7) COVID-19 convalescent
plasma in the context of a clinical trial. The narrative summaries are made of treatments undergoing evaluation.

•

Society of Infectious Diseases Pharmacists review on COVID-19 treatment
The Society of Infectious Diseases Pharmacists summarize the current evidence as of March 18, 2020 to provide guidance on
potential COVID-19 treatment options.

Internal Medicine
•

Impact of the COVID-19 on stroke care and potential solutions
A survey of leaders from 280 stroke centers showed that capacity for stroke care was reduced in the majority of the
hospitals. Most of the stroke centers stopped or reduced public stroke education. Hospital admissions related to stroke
dropped by approximately 40%; thrombolysis and thrombectomy cases dropped by approximately 25%. Recommendations
based on the data are provided. Stroke awareness education activities should be enhanced. Establishing a fast-track COVID19 screening process for patients with potential stroke is highly desirable. A rapid laboratory test for the virus should be
prioritized for patients with stroke, and the test should be part of the existing stroke fast-track pathway. The initiation of
stroke therapy should not be hindered by the COVID-19 screening. Resource management should be established as quickly as
possible. A campaign to encourage appropriate hospital evaluation for emergent, treatable, time-sensitive diseases such as
stroke and myocardial infarction should be initiated at a national level.

•

Managing hypertension during COVID-19 pandemic
The evidence summary on COVID-19 and hypertension is provided as well as practical management recommendations. For
newly diagnosed hypertensive patients initiate calcium channel blockers as first-line therapy in all new patients, irrespective
of ethnicity or age. The initiation of ACEi or ARBS requires repeat blood tests to ensure renal function and potassium levels
remain stable, which might not be readily available. Once health-care systems have less demand towards the end of the year,
consider switching to an appropriate ACEi or ARB. If patients are already on ACEi or ARB, there are currently insufficient data
to suggest cessation of this. Remind patients of ‘sick-day rules’, and if they are unable to drink sufficiently and have diarrhea
or vomiting or a persistently low blood pressure, then their ACEi or ARBs medications should be stopped whilst they recover
to reduce the risk of acute kidney injury. All hypertensive patients are encouraged to procure upper-arm home blood
pressure monitors and to do self-monitoring. This would allow for titration of medication through telemedicine clinics.
Patients should have enough of antihypertensive medications for at least two weeks, as there may be delays in procuring
repeat prescriptions.

Intubation / Extubation / ECMO
•

Caution on early intubation and mechanical ventilation in COVID-19
Annals of Intensive Care review: The authors summarize the data from several articles with conflicting views about
mechanical ventilation as a means to prevent progression to severe lung injury. Some authors believe that vigorous
spontaneous inspiratory efforts can lead to patient self-induced lung injury (P-SILI). Practitioners should consider health
complications associated with mechanical ventilation; however, the authors acknowledge that the idea of de-ventilation
based on P-SILI is radical. The true impact of ventilation during the pandemic may never be known as many factors come into
play.

•

Minimizing droplet and virus spread during and after tracheal extubation
The authors propose a surgical mask to be placed on the patient's face before removing the tracheal tube, and be left on
during transportation, and staying in post-anesthesia recovery room and in the ward. A video demonstration is included.

•

Extracorporeal life support organization in COVID-19: interim guidelines
This is a ‘living document’ developed by the ELSO COVID-19 Working Group on extracorporeal membrane oxygenation
(ECMO) support. The group will remain active for the duration of the pandemic and during any future COVID-19 outbreaks to
revise the guidelines as new information and evidence become available. The most up-to-date version of the guideline
document and all previous iterations can be found on the ELSO website www.elso.org.

•

New methods for safe intubation while managing patients with COVID-19
Current intubation recommendations focus on high-efficiency particulate air (HEPA) filter usage connected between the bag
valve and the patient mask during preoxygenation. After intubation, the HEPA filter is then disconnected from the bag valve
mask and reconnected to the endotracheal tube (ETT). The authors suggest using a closed system with the HEPA filter
already attached to the ETT via either the HEPA-ETT (‘HE’) or ‘Swivel-HEPA-ETT (SHE)-bougie’ methods. The ETT combination
with HEPA filter in advance can potentially reduce aerosolization of the viral droplets from the larynx and trachea during

intubation, and the ventilator can then be connected directly to the HEPA filter after intubation. These two methods can also
allow for confirmation of ETT placement without auscultation, which may be difficult to perform while wearing PP.

•

Intubation in COVID-19 patients: expert recommendations based on case series analysis
By analyzing two retrospective observational case series from Wuhan a panel of international airway management experts
discussed the results and formulated consensus recommendations for the management of tracheal intubation in COVID-19
patients. Strategy and methods for tracheal intubation is recommended.

•

Extubation of patients with COVID-19
The authors propose extubation guidelines for COVID-19 patients aimed at minimizing staff exposure to SARS-CoV-2.

•

Technique for safe intubation/extubation of patients with COVID-19
Can J Anaesth describes a step-wise procedure for safer intubation and extubation of patients with COVID-19.

Laryngectomy
•

Management of total laryngectomy patients during the COVID-19 pandemic
The guide is provided, including the flowchart for determining approach to tracheoesophageal prostheses (TEP). The possible
complications, as well as recommendations for rigorous PPE are described.

Nephrology
•

Canadian Society of Nephrology COVID-19 recommendations on home dialysis
Canadian Journal of kidney health and disease: The review of the recommendations identified 7 broad areas of home dialysis
practice management that may be affected by the pandemic: (1) peritoneal dialysis catheter placement, (2) home dialysis
training, (3) home dialysis management, (4) personal protective equipment, (5) product delivery, (6) minimizing direct health
care provider and patient contact, and (7) assisted peritoneal dialysis in the community. The authors make specific
suggestions and recommendations for each of these areas.

•

COVID-19 and acute kidney injury: summary of NICE guidelines
The National Institute for Health and Care Excellence (NICE) provided guidelines on COVID-19 and acute kidney injury (AKI)
management in hospitals. AKI associated with COVID-19 may be caused by volume depletion, multi-organ failure, viral
infection leading directly to kidney tubular injury, thrombotic vascular processes, glomerulonephritis, or rhabdomyolysis.
Maintaining optimal fluid status (euvolaemia) is critical in reducing the incidence of AKI. Regular assessments of fluid status
and fluid management plans are necessary, and in those who need intravenous fluids the choice of replacement fluid should
be based on patients’ biochemistry panel results and fluid status. An increased risk of coagulopathy may cause problems with
clotting of the extracorporeal circuit during renal replacement therapy.

•

Systemic review: continue use ACEs and ARBs in COVID-19 patients
There are concerns about angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) can
upregulate ACE2 receptor, an entry site for SARS-CoV-2. In a systematic review (unreviewed manuscript in medRxiv), the
authors discuss the results of 8 clinical studies and recommend that ACEIs and ARBs should be continued in patients with
COVID-19. However, larger clinical trials are needed to confirm the safety of these drugs. Individual patient factors such as
ACE2 polymorphism need to be evaluated further.

•

Kidney involvement in COVID-19 and rationale for extracorporeal therapies
The prevalence of direct kidney involvement in novel coronavirus disease is low, but such involvement is a marker of multiple
organ dysfunction and severe disease. The authors explore potential pathways of kidney damage and discuss the rationale
for extracorporeal support with various blood purification strategies in patients who are critically ill.

•

SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Acosta Valley, Northern Italy

Special considerations need to be made for patients receiving some form of renal replacement therapy (RRT) to minimize
their risk. In a preliminary study of two areas in Italy, the hospitalization rate for patients on RRT was 74.6% and the death
rate was 24.6%.

•

Control of COVID-19 in a hemodialysis facility: screening procedures
The reported is experience of a HD facility with 16.1% COVID-19 cases among 230 HD patients and 12.1% cases among 33
staff members. Most HD patients were asymptomatic or had mild clinical signs. None of patients died of severe COVID-19
pneumonia. Procedures for Screening for COVID-19 used in this HD Facility are presented. It is advisable to timely upgrade
PPE, implement universal screening, followed by quarantine and isolation as required.

•

Dialysis and kidney transplantation management during the SARS-CoV-2 pandemic
The therapeutic approach used in Brescia (Italy) for managing COVID-19 patients who underwent kidney transplantation and
are receiving hemodialysis can be viewed as a 2-phase approach. The first phase of disease (0-7 days) is associated with viral
replication and cytopathic effect, therefore antiviral drugs (chloroquine-HCQ, lopinavir/ritonavir, darunavir ritonavir, and
darunavir/cobicistat) may be considered. The second phase of the disease (>7-10 days) is characterized by progressive lung
involvement with escalating needs of oxygen supplementation and ventilatory support, which seems to be secondary to
hyperinflammatory and cytokine release syndromes. Immunosuppressive and immunomodulatory drugs may be of benefit
during this phase. Corticosteroids would be contraindicated in the 1st phase but may play a role in the 2nd phase.

Neurology
•

Ketogenic diet provision during the pandemic: the experience of two US epilepsy diet centers
Ketogenic diet therapy is often started in the hospital, with families educated in hospital-based classes, but this is difficult to
do in this current pandemic. Pediatric and adult epilepsy diet centers had to quickly consider alternative methods to both
start and maintain ketogenic diet therapy. This paper provides several examples (patient cases) of how ketogenic diet
therapy can be provided to patients in unique ways, along with recommendations from other experts and patients, learned
over the past few months. 9 new patients were started on the modified Atkins diet (MAD), and 28 follow-up patients have
been seen to date in this manner. Patient feedback has been overall positive regarding receiving ketogenic diet therapy (KDT)
training and follow-up via telemedicine visit.

•

Guidelines for Neuroscience Community during COVID-19
This review consolidates the current body of literature regarding the neurological impact of coronaviruses, discusses the
reported neurologic manifestations of COVID-19, and highlights recommendations for patient management. Specific
recommendations pertaining to clinical practice for neurologists and neurosurgeons are provided.

•

Consensus for prevention and management of COVID-19 for neurologists
A summary is provided by US and China authors on clinical guidelines and research on management of COVID-19 with
emphasis on neurological manifestations. >30% of patients with COVID-19 report dizziness, headache, impaired
consciousness, acute cerebrovascular disease, ataxia and epilepsy, taste impairment, smell impairment, vision impairment,
neuralgia, or skeletal muscular damage. Neurologists need to wear caps, masks, scrubs, gloves and carry hand sanitizer.
Patients and their companions must have temperature measured in triage routinely before entering the consulting room.
Companions should avoid entering the room. Everyone must wear disposable medical masks. For patients with neurological
symptoms but also highly suspicious of COVID-19, it is recommended that the patient go to a fever clinic first and consult a
neurologist later. After work, doctors should remove the protective gear. It is forbidden to leave the contaminated area
wearing PPE.

•

Guidance for managing electromyography requests and testing during the COVID-19
The authors encourage electrodiagnostic study referrals be stratified into Urgent, Non-urgent and Possibly Urgent. For each
category, they provide a rationale and some examples.

•

ESMINT recommendations for interventional neurovascular management during COVID-19

European Society of Minimally Invasive Neurological Therapy recommendations are provided on several domains: patient
categorization, health care workers precautions, training, angiography suite management, neurointerventional materials and
others.

Neurosurgery
•

Chinese guidelines on prevention and control of COVID-19 during neurointerventional surgery
Chinese Federation of Interventional and Therapeutic Neuroradiology (CFITN) and the International Society for
Neurovascular Disease (ISNVD) compiled an expert consensus on fighting against the COVID-19, including infection
prevention and control procedures in the outpatient/inpatient/catheterization lab settings, medical stuff self-protection,
operating room requirements, management of suspected or confirmed COVID-19 cases, and treatment of emergency stroke
patients.

•

COVID-19 and neurosurgery: review and discussion of guidelines
This literature review has focused on the amount and dynamics of neurosurgery publications without digging into concrete
recommendations. Globally, there has been a broad call to reduce "elective" neurosurgical operations. Consequently,
neurosurgeons are expected to devise alternative plans of how and when to treat non-emergent neurosurgical patients.
Nonetheless, apart from clear-cut emergent cases, the timing of neurosurgery may be crucial, even in some elective
procedures, such as intracranial tumors or cervical myelopathy. These situations often require decision-making coordinated
with senior neurosurgeons.

•

Management of neurosurgical patients during pandemic, Italy
The authors conducted a literature review and share their experience of neurosurgery department’s management during
COVID-19. The approaches suggested include: a) surgical treatment only of urgent cases, b) implementation of “no-visitor
policy”, c) patient classification in 4 risk groups, and d) strict management of operating rooms with use of high-protective
PPEs and the limited number of experienced staff available.

Nuclear
•

The US guidance on operating procedures for a nuclear medicine facility
The guidance provided by The American College of Nuclear Medicine aims to assist nuclear medicine facilities in developing
standard operating procedures for managing a patient under investigation for COVID-19. The recommendations are based on
the current best practices narrated from current literature, as well as publications from the WHO and CDC.

Obstetrics and Gynecology
•

Labor and delivery guidance for COVID-19
The American Journal of Obstetrics & Gynecology MFM provides practical recommendations covering: (1) screening, testing,
and preparation for patient visit and admission (2) screening patients in L&D triage (3) changes to L&D workflow with PPE
and visitor policy (4) intrapartum care (5) postpartum care (6) care for confirmed or suspected COVID-19 patients (7) care for
critically ill COVID-19 pregnant patients.

•

Recommendations for maternal-fetal medicine practitioners during COVID-19
Am J Obstet Gynecol: Italian experts provide the guidelines for maternal-fetal medicine practitioners regarding prenatal visits,
scheduling obstetrical ultrasound, non-stress tests and biophysical profile, visitor policies, and involvement of trainees.

•

Do not separate newborns from contagious mothers
Breastfeed Med article argues separation may not prevent infection, disrupts newborn physiology, stresses mothers, and
disrupts immune protection. No evidence separation improves outcomes. WHO and CDC guidelines differ.

•

Prototype protocol for Cesarean delivery of COVID-19 patients

The protocol was designed to improve staff readiness, minimize risks and streamline care processes for this unique group of
patients. The protocol is adaptable to specific local resources and limitations of individual labor and delivery units. Operating
Room Guide for Confirmed or Suspected COVID-19 Pregnant Patients Requiring Cesarean Delivery.
•

Italy's experience with managing the obstetric services during COVID-19
Italy's Obstetrics Task Force recommendations for the management of pregnant women.

•

International society of ultrasound in obstetrics and gynecology issues safety guidelines
ISUOG Safety Committee released statement on use of personal protective equipment and hazard mitigation in relation to
SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound.

•

Priorities in the management of obstetric COVID-19 patients
The review provides evidence-based recommendations and/or expert opinion for anesthesiologists caring for pregnant
women during the COVID-19 pandemic. Main focus is preparedness and best clinical obstetric anesthesia practice.

•

Universal screening for SARS-CoV-2 is beneficial for obstetrics management: NY hospital experience
Most patients positive for SARS-CoV-2 at delivery were asymptomatic, and more than 1 in 8 asymptomatic patients who were
admitted to the labor and delivery unit were positive for SARS-CoV-2.The potential benefits of a universal testing approach
include the ability to use Covid-19 status to determine hospital isolation practices and bed assignments, inform neonatal
care, and guide the use of personal protective equipment.

•

Management of gynecology patients during pandemic: Chinese recommendations
The experts from the Chinese Obstetricians and Gynecologists Association describe basic infection precaution principles, an
epidemiological screening tool, prioritization of surgical procedures, and operating room requirements. Using these
principles, authors then reviewed management of gynecologic patients during the pandemic in the outpatient and operative
and non-operative inpatient settings, as well as in clinical trials.

•

New strategy for gynecological ward rearrangement and zoning management
Wuhan authors share their strategy to effectively minimize nosocomial infections in gynecology department. The strategy
included the following measures: screening for COVID-19 before inpatient treatment; education; attention to the mental
health of inpatients, their families, and medical personnel; patient redistribution; treatment modifications, use of PPE.

Oncology
•

COVID-19 and gynecological cancer: a review of the published guidelines
International Journal of Gynecological Cancer: This is a detailed review of published guidelines, statements, comments from
peer-reviewed journals, and nationally/internationally recognized professional bodies and societies' web pages.
Recommendations for surgical and oncological prioritization of gynecological cancers are discussed and summarized. The role
of minimally invasive surgery, patient perspectives, medical-legal aspects, and clinical trials are also discussed. The consensus
is that elective benign surgery should cease, and cancer surgery, chemotherapy, and radiotherapy should continue based on
prioritization. Patient and staff face-to-face interactions should be limited, and health resources used efficiently using
prioritization strategies.

•

Lung Cancer: recommendations from the Brazilian Thoracic Oncology Group
CLINICS: Patients should be contacted on the day prior to their visit and questioned whether they, or any of their close
contacts, have had any close contact with COVID-19 patients, or developed COVID-19 symptoms in the last 14 days. This
questioning should be repeated upon their arrival at the clinic. If the patient has/had COVID-19 symptoms or contact with
COVID-19 individuals, their visit should be postponed. If the symptoms are mild, they should be tested for SARS-CoV-2 (PCR nasal swab), put into domiciliary isolation and followed up by telemedicine for 14 days, before restarting treatment. If
symptoms are moderate to severe, the patient should be hospitalized. Limit number of companions to one, and restrict, if
possible, access of companions to the clinic. Patients who tested positive must remain isolated for 14 days after the start of
symptoms or after the date of the test (if asymptomatic). These and other recommendations are provided.

•

Brachytherapy recommendations during COVID-19 pandemic

Practical considerations are discussed for brachytherapy (a form of radiotherapy) for a variety of clinical indications. A
summary is provided on the evidence supporting the use of higher dose-per-fraction high-dose-rate regimens to allow
treatment completion in a shorter course thereby limiting resource utilization and exposure risk. It is strongly recommended
that for all modified fractionations being considered, strict respect for normal tissue dosimetric constraints be met.

•

Review of guidelines on cancer surgery triage
The review focuses on different types of cancers, stating which of them can be postponed and which ones cannot. Thorough
evaluation and discussion by an expert and experienced multidisciplinary team appears to be the most effective way forward
however, the pandemic is likely to have an adverse impact on a number of cancer patients due to the inevitable delay caused
in their treatment.

•

Recommendation for management of cancer surgery cases
The Society of Surgical Oncology (SSO) asked each of the SSO Disease Site Work Group Chairs and Vice Chairs provide their
recommendations for managing care in their specialties, assuming a 3- to 6-month delay in care.

•

Cancer specific guidelines
The recommendations and possible actions are described that should be considered by patients, their caregivers and
families, physician, nurses, managers and staff of medical centers involved in cancer diagnosis and treatment. To goals: 1)
limiting the exposure of cancer patients to medical environments and 2) modifying the treatment modalities in a manner that
reduces the probability of myelosuppression.

•

Guidelines on management of patients with neuro-oncologic disease
Guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology. Framework is
provided for institutions and governments to help adjudicate treatment allocations to patients with neuro-oncologic disease.

•

Urgent considerations for the neuro-oncologic treatment of patients with gliomas
An approach is presented developed by an international multi-disciplinary group to optimize the care of adults with gliomas
during this pandemic. The authors recommend measures to promote strict social distancing and minimize exposures for
patients, address risk and benefit of all therapeutic interventions, pro-actively develop end of life plans, educate patients and
caregivers, and ensure the health of the multi-disciplinary neuro-oncology workforce.

•

Canadian guidelines for managing genitourinary malignancies
Eighteen academic genitourinary medical oncologists from 11 cancer centers across Canada participated in preparing this
guidance document for managing patients during the current pandemic.

•

French Sarcoma Group proposals for management of sarcoma patients
In patients with confirmed/suspected COVID-19, any treatment must be postponed at least 15 days after the start of the
symptoms and when the patient has recovered. Multidisciplinary tumor boards (MDT) with virtual discussion remain the best
option when complex cases have to be discussed. For sarcoma in localized phase, the ESMO Clinical Practice
Recommendations for sarcomas apply without modification for patients without COVID-19 symptoms. It is not recommended
to delay surgery for operable patients without COVID symptoms, in particular, for Grade 2-3 soft tissue sarcoma, bone
sarcoma, GIST and visceral sarcoma. More of the detailed recommendations are provided.

•

Oncology practice during the COVID-19 pandemic
Early reports suggest a substantially increased risk of death associated with COVID-19 infection among patients with cancer.
The authors describe approaches to manage 4 urgency categories of oncology care.

•

Management of immunocompromised cancer patients during COVID-19 pandemic
The review examines the impact of COVID-19 on a cancer patient and discusses management options and recommendation
in addition to highlighting the currently available clinical guidelines and resources.

•

French consensus on management of head and neck cancer surgery during COVID-19

This advice applies to both consultations and surgical procedures and is likely to change on a day-by-day basis. The rule is to
limit as much as possible the number of patients in order to reduce the risks of contamination by the SARS-Cov-2 for both
patients and the caregivers, who are particularly exposed in ENT.

•

US recommendations on cutaneous lymphoma management (pre-proof)
United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas. The authors
propose strategies for treating patients with primary cutaneous lymphoma, including lesions categorization and emphasis on
telemedicine.

•

US recommendations on cutaneous lymphoma management (pre-proof)
United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas. The authors
propose strategies for treating patients with primary cutaneous lymphoma, including lesions categorization and emphasis on
telemedicine.

•

Italian survey on reorganization of medical oncology departments
122 oncologists participated in this survey. Results show that the following measures for oncology facilities have been
promptly implemented throughout the country: use of protective equipment, triage of patients accessing the hospital, delay
of non-urgent visits and use of telemedicine.

•

Management of lymphocyte malignancies in COVID-19 patients: Brazilian recommendations
Practical recommendations are provided on management of lymphoid malignancies during the COVID-19 pandemic, focusing
on minimizing the risk for patients.

•

Esophageal oncologic surgery in COVID-19 emergency: international recommendations
Recommendations of international experts are provided on Esophageal oncologic surgery management.

•

Caring for older adults with multiple myeloma during the COVID-19 pandemic
In this review, strategies are discussed for treatment stratification of multiple myeloma and the goals of care for older adults
with this disorder during the COVID-19 pandemic.

Ophthalmology
•

Safety measures for intravitreal injection during COVID-19 pandemic
Intravitreal eye injections in suspected/confirmed COVID-19 cases should be rescheduled unless permanent vision loss is
anticipated. When injecting in a patient with suspected/confirmed COVID-19 it is prudent to use full personal protective
equipment including gloves, N-95 respirator facemask, gown, and eye-shield/goggles. A summary of other protective
measures is provided.

•

Precautions in ophthalmic practice in a hospital: experience from China
Personal protection measures for ophthalmologists and patients are described, as well as measures for operations and for
disinfection of inspection equipment.

•

Chinese experience against SARS-CoV-2 in ophthalmology
Based on 33 articles published by Chinese scholars, guidelines and clinical practice experience in domestic hospitals, the
authors have summarized the Chinese experience to protect ophthalmologists and patients.

•

Indian guidelines on ophthalmological practices during the COVID-19 pandemic
The All India Ophthalmological Society (AIOS) has recently issued practice guidelines to its 22,000+ members found here. An
editorial in the Indian Journal of Ophthalmology documented what was known about the COVID-19 disease from an
ophthalmologist's point of view- - it can be found here. In this paper, a preferred practice pattern is proposed based on
consensus discussion between some of the leading ophthalmologists in India, major institutional representatives, and the
AIOS leadership. The guidelines are provided for triage, use of PPE, precautions to be taken in the ophthalmologic
department and operating room as well as care of various ophthalmic equipment.

Orthopedics
•

Considerations to be made when resuming elective orthopedic surgeries
Many elective orthopedic surgeries were postponed in the interest of safety and to preserve resources and supplies. Once
COVID-19 stabilizes and elective orthopedic surgeries are considered again, this article suggests employing the use of a
standardized algorithm to address challenges.

Otorhinolaryngology
•

A review of guidelines on nasal, pharyngeal and laryngeal endoscopy procedures
A literature review showed that 24 societies suggested to perform endoscopy procedures only if strictly necessary; one
society recommended to avoid flexible endoscopy in all cases. All national and international societies recommended the
rational use of PPE during the diagnostic procedures such as disposable gowns, gloves, FFP2 or N95 respirators and surgical
masks, and eye protection (goggles or face shield).

•

Recommendations for sinus and anterior skull base surgery: A systematic review
The highest level of personal protective equipment (PPE) is recommended due to potential aerosolization of the virus, and
the use of high-speed powered devices should be avoided. Pre-screening of patients and limiting surgeries to only
procedures should be performed. Face-to-face postoperative visits must be limited.

•

Prevention suggestions for department of otorhinolaryngology head and neck surgery
The suggestions are: 1) routine clinic and ward work for non-emergency patients should be minimized in COVID-19 outbreak
areas; 2) clinic health care workers need to be protected by Grade II or Grade III precautions in COVID-19 outbreak areas,
while Grade III precautions are recommended for surgical staffs; 3) it needs to kept in mind that there is currently no
effective screening method for asymptomatic carriers.

Palliative Care
•

The value of holistic palliative care and hospice services during pandemics
Journal of Pain and Symptom Management: An evidence synthesis on the role and response of hospice and palliative care in
epi/pandemics, to inform response to COVID-19. Hospice and palliative care services should: respond rapidly and flexibly;
produce protocols; shift resources to the community; redeploy volunteers; facilitate staff camaraderie; communicate with
patients/careers via technology; standardize data collection.

•

Grief during the COVID-19 pandemic: considerations for palliative care providers
Managing grief for providers, patients, and their loved ones is amplified by patient isolation, individual’s guilt about the
behavior that led to infection, and the fact that patient’s loved ones are unable to say good bye and/or participate in funeral
rituals. The guidelines for both patients and providers are given, with a table of links to resources on communication,
telehealth, advanced care planning, and self-care.

Pathology
•

Chinese guide to forensic pathology practice for death cases related to COVID-19
Forensic Sciences Research: The Guide to Forensic Pathology Practice for Death Cases Related to COVID-19 (Trial Draft)
describes the background investigation of the death cases, autopsy room requirements, PPE, external examinations, autopsy
practices, and auxiliary examinations.

•

CDC updated guidance for medical examiners, coroners, and pathologists
The changes include recommendations for optimal autopsy tissue specimen collection, including number of recommended
sections from high yield respiratory tissues; acceptable alternatives to nasopharyngeal swabs; timing considerations when
collecting a swab; considerations regarding serologic testing, and patient transportation.

•

Biosafety procedures for cytologic and histologic samples as employed at an Italian institution

Protocols and guidelines for cytologic and histologic samples in use at a large tertiary Italian hospital are presented.

•

Methods for remote pathology work during the COVID-19 pandemic
Using secure video conferencing tools, pathologists at labs and tumor boards can share diagnostically challenging cases
remotely and broadcast the feed on a microscope‐mounted camera as they drive a slide in real time. Pathologists can view
health record information and discuss management plans to minimize disruptions to the practice of academic pathology.

•

Essential laboratory testing in patients with COVID-19
An essential minimal (provisional) list of laboratory tests is provided, which may be recommended for patients with COVID19, and to potentially assist in prognostic monitoring of such patients.

•

The Royal College of Pathologists of Australasia position on COVID-19: IgG/M tests are not diagnostic
A position statement on COVID-19 IgG/IgM rapid point-of-care tests states: 1) Molecular testing on a single throat with deep
nasal swab is the current test of choice for the diagnosis of acute COVID-19 ; 2) COVID-19 IgG/IgM rapid tests play no role in
the acute diagnosis of COVID-19; 3) COVID-19 IgG/IgM rapid tests will miss patients in the early stages of disease when they
are infectious to other people.

Pediatrics
•

Essential services for deaf and hard of hearing children during the COVID-19 pandemic
The authors describe the experience of a quaternary referral pediatric hospital in Seattle, the epicenter of COVID-19, and
share strategies for risk minimization employed by Seattle Children's Hospital. One to 2 months’ delay in care can have
implications for child's language and development. During this time, children may ‘‘fall through the cracks,’’ as centers
reduce their screening or testing practices. Establishing criteria for ABRs, audiograms, hearing devices, cochlear implantation,
or other interventions can help determine what care is essential during the COVID crisis.

•

Clinical management of COVID-19 in critically ill children
Narrative literature review on clinical management, as well as information on PICU preparedness activities.

•

Classification system for newborn infants to guide practice parameters
A rapid classification system has been proposed to aid healthcare workers in evaluating patients, determining infection
control measures, and planning appropriate follow-up. The classification system has 5 mutually exclusive categories: 1)
confirmed, 2) probable, 3) possible, 4) unlikely, 5) not infected. The category is decided considering results of maternal
testing, clinical status of neonate at birth, and results of neonatal testing. Guidelines regarding appropriate diagnostic
methods and interpretation of results for newborn infants are unclear at this time, so this system could prove to be helpful.

•

Specific precautions for pediatric microlaryngobronchoscopy
With 15% of pediatric Covid positive patients being asymptomatic and significant risk of aerosolization of respiratory
secretions during pediatric microlaryngobronchoscopy, recommend: limit to only urgent procedures, wear ENT specific PPE
including eye protection, limit people in the room to essential staff, use laryngeal mask airways before and after procedure.

•

A guide to rapid implementation of telehealth services for pediatric gastroenterologists
The paper provides a guide to the implementation of telehealth services for pediatric gastroenterologists during the COVID19 public health emergency and beyond.

•

Pediatric clinical management of COVID-19: expert consensus guidelines
An experts’ committee was called up to formulate a consensus statement based on the Novel Coronavirus Infection
Pneumonia Diagnosis and Treatment Standards (the fourth edition) (National Health Committee) and other previous
diagnosis and treatment strategies for pediatric virus infections. The present consensus statement summarizes current
strategies on diagnosis, treatment, and prevention of 2019-nCoV infection in children.

•

Recommendations for care of children receiving chronic dialysis at home and hemodialysis centers

The authors have proposed recommendations for prevention and control of SARS-CoV-2 infection and COVID-19 in pediatric
HD centers and in-home PD settings for children who reside in geographic regions where COVID-19 is highly prevalent.
Guidelines include proper hygiene, PPE, disinfection, frequent temperature monitoring, and up to date education.

Pharmacy
•

CDC provides guidelines for pharmacies to reduce pharmacy staff's exposure to COVID-19
The CDC recommends pharmacies provide hand sanitizer for customer use, encourage electronic prescriptions, avoid
touching items handled by customers, avoid touching their own faces, sanitizing hands and counters after interacting with
customers, maintaining 6 feet of social distancing, and removing unnecessary touchable items from the pharmacy.

•

The role of clinical pharmacists in fighting COVID-19 and the innovative strategies for them
The Chinese and English databases, self-media network, website of professional society or medical institution, and clinical
trial center platforms were searched, and clinical pharmacists involved in the work against COVID-19 were surveyed and
interviewed. Clinical pharmacists can give full play to their professional expertise, analyze the current situation rationally,
formulate telehealth strategies swiftly, and work in a united and efficient manner to provide innovative pharmacy services to
ensure medication safety and rational use of medicine.

•

American Society of Health-System Pharmacists updated evidence on current COVID-19 treatments
The American Society of Health-System Pharmacists (ASHP) provides a table of evidence of various treatments in use for
COVID-19.

Psychiatry
•

Guidelines to improve care for people with mental illnesses during COVID-19
Community Mental Health Journal: US authors suggest different methods of service delivery for people with mental illnesses.
This includes community outreach, digital intervention, clinic-based care, telemedicine, as well as connecting patients to
resources and support lines. These methods can be used to assess safety, address urges to use substances, manage medical
needs, as well as being a source of information. Marginalized members of the community are already at risk of not receiving
equal care. Authors believe these techniques can bridge the gap and provide aid to those in need.

•

Rapid conversion of an outpatient psychiatric clinic to virtual telepsychiatry clinic
The outpatient psychiatric clinic at UC Davis Health, in which 98% of visits initially occurred in person, was converted to a
telepsychiatry clinic, with all visits changed to virtual appointments within 3 business days. The clinic had 73 virtual
appointments on its first day after full conversion. This column describes the process, challenges, and lessons learned from
this rapid conversion. Patients were generally grateful, providers learned rapidly how to work from home, and the clinic
remained financially viable with no immediate losses.

•

Electroconvulsive therapy for geriatric depression during COVID-19 pandemic
The authors describe their approach to conducting ECT in depressed geriatric patients in Canada. They implemented a
rigorous patient prioritization process with color-coded cases classification (red -emergent, orange -highly urgent, yellow urgent but can wait for up to 4 weeks, green -can be clinically monitored without treatment but provide quick access if the
acuity changes, gray -stable long term). Patients selected for treatment were screened clinically for COVID-19, and if positive,
were tested with PCR. They also went through a revision of the informed consent procedure to reflect the added risk of
infection. ECT was then performed in a room modified to provide negative pressure and allow optimum air circulation
between patients. All staff were geared in full PPE changed between patients while the room was ventilated and sterilized.

•

Long acting injectable antipsychotic medications continued under modified clinic workflow
University of Pittsburg psychiatric ambulatory clinic sought to maintain long acting injectable antipsychotic medications for
their patients with serious mental illness. The clinic's modified workflow, experienced staff, and rapport with patients allowed
for continuation of scheduled injection appointments with minimal dropout or change to oral medications.

•

Managing obsessive-compulsive disorder during COVID-19 pandemic
International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive and Related
Disorders Research Network (OCRN) of the European College of Neuropsychopharmacology lay guidelines for OCD treatment
that include prioritizing evidence-based pharmacotherapy, temporarily modifying or pausing face-to-face CBT with exposure
and response prevention. Assess suicidal risk, provide psychoeducation, inquire about Internet usage and news consumption.

•

Mental health endangered during COVID-19 Pandemic
The COVID-19 pandemic has implications for emotional and social functioning. In addition to providing medical care, already
stretched healthcare providers have an important role in monitoring psychosocial needs and delivering psychosocial support
to their patients, health care providers, and the public. These activities should be integrated into the general health care.

•

Opportunities and challenges for psychiatric service during COVID-19
Recommendations are given on patient care, advocacy, supporting the colleagues and the system, as well as on scholarship.
Challenges to providing consultation-liaison psychiatric care in the COVID-19 settings are described.

•

Guidance for psychiatrists and support for patients: Royal College of Psychiatrists resources
The website of the Royal College of Psychiatrists provides information, advice and support for psychiatrists, patients, and
their careers. This includes free webinars, expert’s interviews, telephone peer support for psychiatrists, and latest COVID-19
news: www.rcpsych.ac.uk

•

Consensus statement on the use of clozapine during the COVID-19 pandemic
Recommendations from the international expert advisory subgroup of the Treatment Response and Resistance in Psychosis
working group. Due to risk of clozapine-associated severe neutropenia, absolute neutrophil count (ANC) monitoring
programs are a prerequisite for clozapine dispensation in most jurisdictions globally. They recommend: 1) Reduction in
testing to once per 3 months if patient on drug for 1 year and has had no ANC issues, or if safe testing not practical; 2)
Immediate exam, including CBC if COVID-19 symptoms appear; 3) Reduce dosage by as much as 1/2 if COVID-19 symptoms
appear, due to risk of toxicity of rising clozapine levels during acute infection, stepping dosage up incrementally after
symptoms resolve.

•

Multidisciplinary research priorities for COVID-19: mental health science call for action
This position paper summarizes the priorities put forward by an interdisciplinary group of 24 world-leading experts, including
people with lived experience of a mental health issue, from across the bio-psycho-social spectrum of expertise in mental
health science in March and April, 2020. The survey findings, combined with the published scientific literature, informed the
development of the research priorities.

•

ADHD management during the COVID-19 pandemic
The European ADHD Guidelines Group proposes approaches for diagnosis, follow-up assessments, behavioral management,
and pharmacological management of ADHD in the context of pandemic challenges.

•

Mental health resources for COPD population during the pandemic
Patients with chronic obstructive pulmonary disease (COPD) are at a higher risk for COVID-19 as well as for depression and
anxiety. The COPD foundation provides resources on maintaining emotional well-being for patients, their families and
caregivers: https://www.copdfoundation.org/downloads/MainEmtn-Health-FINAL.pdf

•

Adaptation of health workers to grief
“Brain, behavior and Immunity” discusses grief experienced by frontline healthcare workers in response to patient death.
Loss adaptations (continually adjusting to changes) should be preferred over loss coping (time-limited response with specific
skills). Mental health professionals should encourage the exploration and employment of adaptive strategies (affective,
cognitive, behavioral, physical, spiritual) consistent with grievers’ personality and situation. Identifying and developing
resilience traits (self-efficacy and social support) will empower grievers to adapt.

•

Electroconvulsive therapy should be considered as an essential procedure even during COVID-19

Hospitals around the world closed down their electroconvulsive therapy (ECT)-units. Belgian authors claim that ECT should be
seen as an essential medical procedure and made available in order to prevent long-term mental health consequences in
adults with serious mental illness. The caveats and measures to undertake for ECT are described.

Pulmonary
•

German position statement on respiratory support in patients with COVID-19
Respiration: German Respiratory Society present key position statements including observations about the pathophysiology
of acute respiratory failure (ARF). Pulmonary damage in advanced COVID-19 often differs from the known changes in ARDS.
Two types (type L and type H) are differentiated, corresponding to early- and late-stage lung damage. The assessment of the
extent of ARF should be based on arterial or capillary blood gas analysis under room air conditions, and it needs to include
the calculation of oxygen supply. Aerosols can cause transmission of infectious, virus-laden particles. Open systems or vented
systems can increase the release of respirable particles. Procedures in which the invasive ventilation system must be opened
and endotracheal intubation carried out are associated with an increased risk of infection. PPE should have top priority
because fear of contagion should not be a primary reason for intubation. Inhalation therapy, nasal high-flow therapy (NHF),
continuous positive airway pressure (CPAP), or noninvasive ventilation (NIV) can be performed without an increased risk of
infection to staff if PPE is provided. A significant proportion of patients with ARF present with relevant hypoxemia, which
often cannot be fully corrected, even with a high inspired oxygen fraction (FiO2) under NHF. In this situation, the oxygen
therapy can be escalated to CPAP or NIV when the criteria for endotracheal intubation are not met. In ARF, NIV should be
carried out in ICU or a comparable setting by experienced staff. Under CPAP/NIV, a patient can deteriorate rapidly. For this
reason, continuous monitoring and readiness for intubation are to be ensured at all times. If the ARF progresses under
CPAP/NIV, intubation should be implemented without delay in patients who do not have a "do not intubate" order.

•

Managing chronic obstructive pulmonary disease: FAQ and support program
This commentary summarizes the Canadian Thoracic Society’s position statement on managing COPD during the COVID-19 in
an easy FAQ format. The full COPD position statement, as well as other valuable clinical tools including links to online patient
support programs for self-management and exercise/pulmonary rehabilitation, can be found at https://cts-sct.ca/covid-19/.

•

Bronchoscopy during the COVID-19 pandemic: review of guidelines
An expert panel report published in Chest identifies 6 statements including 1 evidence-based graded recommendation and 5
ungraded consensus-based statements. Bronchoscopy should be used sparingly in the evaluation and management of
patients with suspected or confirmed COVID-19. In an area where community transmission of COVID-19 is present,
bronchoscopy should be deferred for non-urgent indications. Health care workers should wear PPE while performing the
procedure even on asymptomatic patients.

•

Chinese protocol for COVID-19 pneumonia diagnosis and treatment
Chinese Medical Journal provides a summary of COVID-19 -related evidence and the guidelines to manage the disease.

•

Summary of guidelines from 5 Bronchology societies
Disparate bronchoscopy guidelines are collected and harmonized in a short commentary.

•

A consensus for non-ICU ARF SARS-CoV-2 emergency in Italy
Italian respiratory scientific societies propose an early consensus statement for emergency management of non-ICU ARF
SARS-CoV-2. It represents the expert opinion of pulmonologists directly involved in the first line of assistance. The Consensus
identified two urgent areas for action: a) management, and b) organization

•

Respiratory support outside the intensive care unit: non-invasive ventilation benefits
Non-invasive ventilation (NIV) is a well-established therapy. As many as 50% of COVID-19 patients admitted to ICU stay on
NIV and do not subsequently require invasive mechanical ventilation (IMV). Evidence from China suggests that a large
minority of patients with severe respiratory failure due to SARS-CoV-2 can avoid IMV via NIV. Careful monitoring required.

•

Renin angiotensin blockers and COVID-19: current evidence and recommendations

1. In noninfected patients and patients at risk, there is currently no valid reason to discontinue RAS blockade; 2.In healthy
subjects at risk, evidence is not (yet?) sufficient to prophylactically recommend RAS blockade; 3.If apprehension about
increased infectivity persists, patients on ACEIs or ARBs could temporarily be switched to a direct renin inhibitor; 4. In COVID19-positive patients on RAS blockers, the drugs should be continued; 5. In febrile patients with pulmonary symptoms on RAS
blockers, close monitoring of blood pressure and renal function is advisable; RAS blockers should be discontinued only as
clinically indicated.

•

Preliminary recommendations for lung surgery during COVID-19 epidemic
In this commentary proposal, the nucleic acid test of SARS-CoV-2 is not taken as the gold standard for positive or negative
new coronavirus (unverified techniques, lack of uniﬁed standards, variable tests speciﬁcity and sensitivity, many false
negative results). Epidemiological exposure history, clinical characteristics, routine biochemical test including CRP and
comprehensive review of chest CT are important judgment bases before pulmonary surgery is considered. The isolation and
observation for two weeks before the operation is helpful to further exclude the possibility of new COVID-19pneumonia.

•

CDC’s factsheet for patients with respiratory symptoms to manage their care at home
CDC’s new factsheet explains 10 ways people can manage their care at home. 1. stay home, 2. monitor your symptoms, 3.
get rest and stay hydrated, 4. call the healthcare provider if you have symptoms, 5. notify the dispatch personnel, 6. cover
your cough and sneezes, 7. wash your hands often, 8. stay away from other people, 9. avoid sharing personal items, 10. clean
all surfaces.

•

A new technique for daily checks of anesthetic machines to ventilate the lungs
The authors describe a new process for daily checks of anesthetic machines. Each circuit disconnection potentially generates
an infectious aerosol and risks tracheal tube displacement and lung derecruitment. The authors concluded that multiple
circuit disconnections are unsatisfactory and devised a process for daily checks with a single disconnection per patient.

•

Management of COVID-19-related respiratory distress
JAMA: An expert discusses acute respiratory-distress syndrome (ARDS) manifestations and management strategy.

•

Benefits of high-flow nasal cannulas over ventilators: University of Chicago report
To check the “truly remarkable” effect of high-flow nasal cannulas reported by the local practitioners, a team from U Chicago
Medicine’s emergency room took dozens of COVID-19 patients who were in respiratory distress and gave them HFNCs
instead of putting them on ventilators. The patients all fared extremely well, and only one of them required intubation after
10 days.

•

A protocol for prone positioning in SARS (University of Nebraska Medical Center)
The protocol is presented for prone positioning in patients with Severe Acute Respiratory Distress Syndrome, to avoid putting
patients on mechanical ventilators if possible at all. A video is available here.

Radiology
•

Chinese Society of Interventional Radiology expert consensus on in interventional radiology procedures
Quantitative Imaging in Medicine and Surgery: The key points include the following: 1) non-emergency interventional
diagnosis and treatment should be suspended while work is ongoing to prevent and control the spread of COVID-19; 2)
protective measures should be taken according to the appropriate level designated for COVID-19 infection prevention and
control; 3) patients should take measures to protect themselves when they want to see a doctor.

•

American college of radiology statement on safe resumption of routine radiology care
A comprehensive management strategy includes consideration of local COVID-19 statistics; availability of PPE; local, state,
and federal government mandates; institutional regulatory guidance; local safety measures; health care worker availability;
patient and health care worker risk factors; factors specific to the indication(s) for radiology care; and examination or
procedure acuity. If the risk of illness or death to a health care worker or patient from health care-acquired COVID-19 is
greater than the risk of illness or death from delaying radiology care, the care should be delayed; however, if the opposite is
true, the radiology care should proceed in a timely fashion.

•

Integrated radiologic algorithm for COVID-19 Pandemic
On the basis of scientific data, knowledge in thoracic radiology, and their Institutional experience with COVID-19 , the authors
drew and adapted an integrated radiologic algorithm based on the first 702 cases of patients in Italy who referred to
dedicated COVID-19 radiology protocol after first-level clinical triage in a dedicated emergency unit.

•

Lung ultrasonography advantages for management of COVID-19
"Based upon our experience, we consider that lung ultrasonography has major utility for management of COVID-19 with
respiratory involvement due to its safety, repeatability, absence of radiation, low cost and point of care use; chest CT may be
reserved for cases where lung ultrasonography is not sufficient to answer the clinical question."

•

Expert Panel gives consensus statement on role of chest imaging
There are 5 main recommendations: 1. Imaging is NOT indicated for screening COVID-19 in asymptomatic persons. 2. Imaging
is NOT indicated for patients with mild features of COVID-19, unless there is high risk for disease progression 3. Imaging IS
indicated for patients with moderate to severe features regardless of COVID-19 test results. 4. Imaging IS indicated for
confirmed cases of COVID-19 with worsening respiratory status 5. In areas of constrained resources with limited access to CT,
CXR may be preferable unless degree of progression warrants use of CT.

•

Use of chest CT as the main screening method in epidemic areas is recommended
Clinicians should be cautious that CT findings in afebrile/asymptomatic patients are not less alarming than the findings in
symptomatic patients. These patients should also be quarantined.

•

Infection control in departments of radiology
Multiple cases of COVID-19 transmission in radiology department have been reported. Here the authors summarize the
lessons they learned and provide suggestions to improve infection control and prevention practices of healthcare workers in
departments of radiology.

•

Early detection of asymptomatic infections using chest CT
Chest CT discovered 24 out of 25 asymptomatic patients. Of these 16 recovered without any symptoms. Therefore, chest CT
is critical in the diagnosis of COVID-19. It is simple and easy to use.

•

CT imaging useful in diagnosis and rating severity of disease
High-resolution CT imaging discloses specific pattern in COVID-19 pneumonia and is able to differentiate various levels of
severity for prognosis and treatment planning.

•

A program for infection control in the medical imaging department
Based on guidelines and protection experience, radiologist-nurse-radiographer interactive emergency management program
(RNRIEMP) optimizes the examination process for patients with fever. This program can optimize the examination process of
patients with fever, reduce the risk of staff infection, cross-infection, and maximize savings of medical resources.

•

Mitigating gaps in radiology department: establishing an izolation zone for patients not fully cleared
The loopholes in infection control and prevention practices against COVID-19 in 2 radiology departments are due to poor
understanding of the emerging disease which can be fixed by establishing an isolation zone for patients not completely
cleared of SARS-CoV-2 infection.

•

Prevention and control measures in radiology department during COVID-19 pandemic
The authors summarize the consensus recently presented under the endeavors of radiologists and radiological technologists
led by the Chinese Society of Imaging Technology, Chinese Medical Association, aiming to guide the prevention and practical
work in the radiology department.

•

Singapore radiology department strategies to prevent COVID-19 spread
The authors’ highlights are: 1) Radiology departments should ensure adequate portable imaging capabilities, manpower
demands, and PPE stock in this time of outbreak. 2) Strict infection control practices, heightened levels of hygiene, and
rigorous cleaning are essential in reducing spread of COVID-19. 3) Physical and temporal staff segregation with deliberate
limitation of staff-to-staff interactions.

•

"Mass Casualty Incident Planning" to prepare the radiology departments
The recommendations for developing and implementing a mass casualty incident (MCI) plan for a viral outbreak, such as the
current COVID-19. The MCI plan consists of preparation, mobilization of resources, imaging chain, adjusting imaging
protocols, and education, such as MCI plan simulation and in-service training. Having an MCI plan in place for a viral outbreak
will protect patients and staff and ultimately decrease virus transmission.

•

North America consensus statement on reporting CT findings related to COVID-19
The guidance of the Radiological Society of North America Experts Endorsed by the Society of Thoracic Radiology, the
American College of Radiology, and RSNA are provided to radiologists on reporting CT findings potentially attributable to
COVID-19 pneumonia, including standardized language to reduce reporting variability. When features of COVID-19
pneumonia are present in endemic areas, contact referring providers to discuss the likelihood of viral infection.

•

Safe ultrasound examination and equipment clean-up: international guidelines
This statement of the World Federation for Ultrasound in Medicine and Biology describes the guidance on equipment
cleaning and safe performance of ultrasound examination within the context of COVID-19.

Rheumatology
•

EULAR recommendations for the management of rheumatic and musculoskeletal diseases
BMJ: European League Against Rheumatism recommendations. Patients with rheumatic and musculoskeletal diseases (RMD)
who do not have suspected or confirmed COVID-19 should be advised to continue their treatment unchanged, namely
NSAIDs, glucocorticoids, sDMARDs, bDMARDs, osteoporosis medications and analgesics. If the RMD and its drug treatment
are stable, and signs or symptoms of drug toxicity are absent, regular blood monitoring and face-to-face rheumatology
consultations can be postponed temporarily. Consultation can take place remotely. If the RMD is active, if drug therapy has
recently been started or needs adjustment, or if signs or symptoms of drug toxicity emerge, patient and rheumatologist
should liaise, weigh the risks of a visit to the clinic against the limitations of remote advice and decide together. If a patient
with RMD is offered an outpatient, day care or other type of hospital appointment, patients and members of the
rheumatology team should follow local guidance for infection prevention and control, including the use of PPE if indicated.
Patients with RMD without COVID-19 symptoms who have been in contact with a SARS-CoV-2-positive person should be
tested for SARS-CoV-2. If a patient with RMD and symptoms of COVID-19 is chronically treated with glucocorticoids, this
treatment should be continued. If patients with RMD experience mild symptoms of COVID-19, potential treatment changes in
DMARDs should be discussed on a case-by-case basis. Patients with RMD and initially mild symptoms who experience
worsening of COVID-19 symptoms should immediately seek further healthcare advice of an expert in treating COVID-19, such
as a pulmonologist, an internist or a specialist in infectious diseases. Inpatients with RMD who are admitted due to
significant, COVID-19 should follow local treatment recommendations for COVID-19 as applied by the treating expert.
Patients with RMD without symptoms of COVID-19 should be advised to update their vaccination status in accordance with
the EULAR recommendations for the vaccination of patients with RMD, with a focus on pneumococci and influenza. In
patients with RMD treated with cyclophosphamide or glucocorticoids, Pneumocystis Jiroveci pneumonia prophylaxis should
be considered.

•

Patients with cutaneous auto-immune conditions can continue treatment unless COVID positive
Immunosuppressed patients are not at an increased risk of severe manifestations of COVID-19 compared with the general
population. Experts on immune-mediated disease suggest continuation of treatment during the outbreak to prevent disease
flares that could otherwise increase healthcare use and patient burden. Experts say immunosuppressive/biologic therapy can
be discontinued/postponed if a patient contracts COVID-19, but it should a shared decision on a case-by-case basis.

•

Researchers caution against physical inactivity for patients with rheumatic disease
Self-isolation and quarantine requirements lead to decreased physical activity; however, exercise is major component of
treatment for patients with rheumatic diseases and is associated with including maintained physical capacity/ functionality,
decreased disease acuity, decreased obesity and insulin resistance, and an improved quality of life. Patients living with

rheumatic disease could have a reversal of all the benefits of exercise should their activity levels decrease, and these
individuals should receive additional support during this time and avoid prolonged periods of time spent sitting.

•

Rheumatologists' perspective: discontinue disease-modifying antirheumatic drugs during infection
Patients with COVID-19 may have features mimicking rheumatic diseases. For those with actual rheumatic diseases, until
further evidence emerges, it may be cautiously recommended to continue glucocorticoids and other disease-modifying
antirheumatic drugs (DMARDs) in patients receiving them but discontinue DMARDs during infections per standard practice.

Sleep Disorder
•

Canadian Thoracic Society's statement on management of sleep disordered breathing
Sleep Disordered Breathing (SDB) includes diseases such as obstructive sleep apnea and central sleep disorders (e.g.,
associated with neuromuscular disease, opioid use, congestive heart failure). This commentary summarizes the Canadian
Thoracic Society’s position statement on managing SDB during the COVID-19 pandemic in an easy FAQ format. The full SDB
position statement, as well as other valuable tools and resources, can be found at https://cts-sct.ca/covid-19/.

•

Early CPAP and proning show improved patient outcomes
MedRxiv: In this retrospective observational study at Bradford patients admitted with a positive COVID-19 PCR were
included. Negative patients were also included where clinical suspicion remained high (a total N=559). 9.5% received
continuous positive airway pressure (CPAP), 7.2% were admitted to ICU and 4.8% were ventilated. Hospital mortality was
33.3%, ICU mortality was 54.5%. Following CPAP, 64% of patients with moderate or severe ARDS at presentation, who were
candidates for escalation, avoided intubation during their stay. Bradford had a markedly lower ICU admission and intubation
rate than the ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) cohort (p<0.0001), with
comparable hospital mortality overall and for ICU patients

Surgery
•

Brazilian recommendations for laparoscopic surgery during the COVID-19 pandemic
Rev Col Bras Cir: Recommendations are provided from the Brazilian College of Surgeons.

•

Recommendations on hepatobiliary surgery during COVID-19 pandemic
Clinics and research in Hepatology and Gastroenterology. Chinese and Harvard authors standardized the procedures for outpatients and hospitalization hepatobiliary surgery and divided the surgery into three categories: elective, limited, and
emergency. Patients with no COVID-19 who required limited-term or emergency surgery can have open surgery. It is
important to reduce the operation time, medical staffs’ exposure, and the impact of pneumoperitoneum on lung expansion.
It is recommended to use anesthesia intubation under general anesthesia to reduce the exposure risk of anesthesiologist. A
one-time use filter can be placed between the tracheal intubation and breathing circuit to reduce contamination of the
breathing circuit. Laparoscopic surgery has the advantages of being more rapid and comprehensive in the exploration of the
abdominal cavity in emergency and limited hepatobiliary surgery. Once the operating room receives an alert of a suspected
or confirmed new type of coronavirus infection, prepare the room in accordance with the three types of isolation protocols,
droplet, air, and contact isolation, and provide level three protection accordingly. The hospital should prohibit patient sitter
as much as possible More effort should also be invested in the online follow-up.

•

French guidelines for management of spinal surgeries during COVID-19 pandemic
World Journal of Clinical cases: French Spine Surgery Society elaborated 3 levels stratification of patient cases: Level I: Urgent
surgical indications: cervical or lumbar radiculopathy with acute motor deficit; disc herniation with cauda equina syndrome;
spinal epidural hematoma; septic conditions including epidural abscess, spinal fractures with neurologic deficit; spinal tumors
with neurologic deficit. Level II: Surgical indications associated with a potential loss of chance for the patient: radiculopathy
with hyperalgesia, cervical myelopathy with rapidly progressive neurologic signs, unstable vertebral fracture without
neurologic deficit, unstable spine tumor without neurologic deficit. Level III: Non-urgent surgical indications: degenerative
spinal conditions without neurologic deficit, spinal deformities, revision surgery related to previous instrumentation failure

without instability or neurologic deficit. The authors also report French experience in a COVID-19 cluster region illustrated by
two clinical cases.

•

Restarting essential surgery during COVID-19 pandemic
The authors from Harvard propose interim safety recommendations for patients with no known COVID-19/previously
infected with COVID-19 who are being considered for a surgery.

•

Practical tips for a safe, successful and sustainable reboot of elective surgery
7 practical tips are proposed, to be considered in stepwise progression, for healthcare systems looking to reboot their
elective surgeries: 1) Know where you are on the epidemic curve; 2) Ensure access to reliable COVID-19 screening; 3)
Understand hospital resources; 4) Ensure appropriate case selection and prioritization; 5) Optimize the patient’s postdischarge planning; 6) Start small, stay current and be adaptable; 7) Be prepared for roadblocks ahead.

•

Surgical strategies during the COVID-19 crisis: The Salzburg Concept
A specialized "COVID Surgery Service (CSS)” was created in Austria, exclusively dealing with the COVID patients, comprised of
6 surgeons as part of a newly established COVID-clinic. CSS provides a practical schematic algorithm for surgery strategy in
infected/suspected COVID-19 patients.

•

Systematic review of recommended operating room practice during pandemic
All recommendations were based on low levels of evidence. The highest number of overlapping recommendations related to
physical OR (n=8) and procedural factors (n=13). Although few recommendations were related to personnel factors,
consensus was high in this domain, with all studies mandating the use of PPE. Within the operating suite, common
recommendations focused on room design, in particular geographic segregation of COVID-19 positive areas and the use of
negative pressure ventilation. All recommended health questionnaires and nasal or nasopharyngeal swabs as a minimum to
screen surgical patients, with additional thoracic CT screening recommended by almost half of the sources.

•

The UK recommendations for pre-operative patient testing
The British Journal of Oral and Maxillofacial Surgery issued the following recommendation for pre-op testing (for both PCR
and antibody (Ab) tests): after admission in isolation 24-Hr before the surgery, if the patient has PCR- and Ab+ or PCR and Ab,
carry on the surgery; if the patient is PCR+ and Ab-, postpone the surgery until recovery.

•

Guidelines for surgery in COVID-19 patients
Major Italian surgical and anesthesiologic societies: ACOI, SIC, SICUT, SICO, SICG, SIFIPAC, SICE, and SIAARTI recommend
clinical pathways for COVID-19-positive patients requiring acute non-deferrable surgical care.

•

Recommendation for management of cancer surgery cases
The Society of Surgical Oncology (SSO) asked each of the SSO Disease Site Work Group Chairs and Vice Chairs provide their
recommendations for managing care in their specialties, assuming a 3- to 6-month delay in care.

•

A successful rapid response by an academic surgical department to COVID-19
The successful strategy of a single academic health system is outlined: (1) develop a cohesive leadership team and system for
frequent communication throughout the department; (2) ensure adequate hospital capacity to care for an anticipated influx
of COVID-19 patients; (3) safeguard supplies of blood products and personal protective equipment to protect patients and
providers; and (4) prepare for an unstable workforce due to illness and competing personal priorities such as childcare.

•

Steps for tracheotomy in COVID-19 patients: A staff-safe method for airway management
Tracheostomy in intubated COVID-19 patients requires adjunctive safeguards. A step-by-step approach named CORONA is
proposed in order to recall essential recommendations during the surgical procedure.

•

Peri-operative urgent surgical care of orthopedic patients
Journal of the American Academy of Orthopedic Surgeons article provides operating rooms protocols and recommendations
on personal protective equipment and other approaches to control COVID-19 in orthopedic services.

•

The algorithm for elective surgery risk stratification during COVID-19 pandemic

Elective surgery cancellations might have a more dramatic impact on health than COVID-19 morbidity and mortality. The
paper provides a decision-making algorithm based on elective surgical indications and predicted perioperative utilization of
critical resources, including consideration for intra−/postoperative blood product transfusions, estimated postoperative
hospital length of stay, and the expected requirement for prolonged ventilation and need for postoperative ICU admission.

•

IFSO recommendations on metabolic and bariatric surgery during COVID-19 epidemic
The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has issued these recommendations
for global healthcare providers to help keep patients and practice staff safe.

•

UK recommendations on testing for COVID-19 in patients planned for surgery
The UK recommends that patients scheduled for surgery are assumed to be potential carriers of the virus throughout the
duration of their hospital stay, even if they pass an initial screen for temperature, respiratory symptoms, and exposure or
travel history. A flowchart is presented to help guide COVID-19 testing and surgery planning for these patients.

•

Skull base surgery during the Covid-19: Italian Skull Base Society recommendations
Only urgent surgical operations are recommended, and all patients should be tested at least twice (on days 4 and 2 prior to
surgery). For positive patients, procedures should be postponed until after swab test is negative. If the procedure is vital to
the survival of the patient, FFP3 and/or PAPRs devices, goggles, full-face visor, double gloves, water-resistant gowns and
protective caps, are mandatory. For negative patients, use of at least FFP2 mask is recommended. In all cases the use of
drills, which promote the aerosolization of potentially infected mucous particles, should be avoided. Given the potential
neurotropism of SARS-CoV-2, dura handling should be minimized.

•

Guidelines for tracheostomy: American Association for the Surgery of Trauma
The guidelines from the Critical Care and Acute Care Surgery Committees of the American Association for the Surgery of
Trauma are provided on tracheostomy in known or suspected Covid-19 patients.

Thoracic
•

Thoracic Surgery Outcomes Research Network Guidance for triage of thoracic malignancies operations
Guidance for Triage of Operations for Thoracic Malignancies.

Thrombectomy
•

Brazilian guidance on managing thromboembolic complications in COVID-19
The analysis of the peripheral blood smear, platelet count, PT, aPTT, fibrinogen and D-dimer are recommended for all
hospitalized patients at admission.These parameters should be regularly monitored in critically ill patients. The most
adequate time interval between tests is uncertain and testing should be based on clinical indication, assays availability and
the local laboratory capacity and facility. Perform venous compression Duplex scan at admission of ICU patients and then on
a regular basis, whenever available and at convenient intervals, to detect DVT and to prevent its complications. Maintain
vigilance for clinical and echocardiographic signs of PE. The diagnosis of DIC does not indicate anticoagulation, unless a
thrombotic event is present anticoagulants in COVID-19 should be restricted to prophylaxis of VTE or the treatment of
thrombotic events. All patients hospitalized for suspected or confirmed COVID-19 should receive pharmacologic
thromboprophylaxis. Use LMWH at a standard dose for thromboprophylaxis. However, the benefit of this approach has not
yet been confirmed and trials are needed to address this question. Prophylaxis for thrombosis should be prescribed during
the entire hospitalization period. Maintain prophylaxis after the hospital discharge for patients at high risk of thrombosis or
for those with immobility. Acute VTE events should be confirmed by imaging tests. In the case this is not feasible,
presumptive diagnosis of an acute VTE event may be made based on clinical history, combined with physical examination,
labs and other available tests. Use LMWH for the treatment of acute VTE. Alternatively, UFH or fondaparinux can be used.
Switching DOAC and AV K to LMWH if the patient is admitted to the ICU or is at risk of significant drug–drug interaction.

•

Stroke thrombectomy recommendations during COVID-19

The Society of NeuroInterventional Surgery provides the recommendations on the management of stroke thrombectomy
with an emphasis on safety measures for healthcare providers.

•

Management of venous thromboembolism during COVID-19: an expert consensus before guidelines
Practical recommendations are suggested, including on how to choose thromboprophylactic measures for patients with
diverse severity of disease and bleeding risk, and which kind of anticoagulant should be prescribed.

•

Urgent call for ultrasound screening: 22% of ICU SARS-CoV-2 patients have venous thrombotic events
The reported is the experience of Italian practitioners: 22.2% of patients (83% male, 68 ± 7 years old; BMI 29.3 ± 4.4 kg/m2; Creactive protein 25.7 ± 9.2 mg/dl, fibrinogen 657.1 ± 200.6 mg/dl) admitted to ICU due to SARS-CoV-2 interstitial pneumonia
had venous thrombotic events.

•

Thromboembolic complications of COVID-19: Netherlands health care authorities’ report
The National Institute for Public Health of the Netherlands asked the experts of Radiology and Vascular Medicine to provide
guidance for the imaging workup and treatment of thrombotic important complications. A question-answer format is used.

Tracheostomy
•

Novel approach to reduce transmission of COVID-19 during tracheostomy
A novel approach is introduced for better protection and reduced transmission for tracheostomy in a COVID-19 positive
patient. This technique is functional, easy to set up, and can be used for additional operations that involve risk of
aerosolization or droplet exposure to operating room staff.

•

Tracheostomy procedure during the Covid-10 outbreak
The surgeons’ modified guidelines are: 1) all procedures should be done under general anesthesia, with deprivation of
spontaneous respiration and application of muscle relaxants, regardless of whether patients had spontaneous breathing or
not; 2) after the cervical trachea is exposed and immediately before an incision is made in the trachea, the endotracheal tube
is inserted deeper, positioned with the tip close to carina of the trachea; 3) when the opening is complete, brief interruption
of the ventilator is essential.

•

The New York Head and Neck Society recommendations for tracheostomy during COVID-19 pandemic
This study summarizes the precautions that should be taken to ensure successful tracheostomy.

•

A novel negative-pressure aerosol cover for COVID-19 tracheostomy
The authors from Washington University in St Louis present their novel negative-pressure aerosol cover made of readily
available operating room materials as an additional barrier to limit the spread of aerosols during tracheostomy. They were
able to perform a complete open tracheostomy procedure while operating entirely under this cover. As the highest risk for
aerosolization begins when the airway is entered, it is reasonable to deploy the cover immediately prior to this portion of the
procedure. The cover setup was generally easy to perform and able to be completed in less than 5 minutes.

Urology
•

A systematic review of guidelines and recommendations for urology standards of care
European Urology Focus: Of the 15 studied guidelines 14 addressed emergency situations and 12 reported on assessment of
elective uro-oncology procedures. There was consensus on postponing radical prostatectomy except for high-risk prostate
cancer, and delaying treatment for low-grade bladder cancer, small renal masses up to T2, and stage I seminoma. According
to 9 guidelines that addressed endourology, obstructed or infected kidneys should be decompressed, whereas nonobstructing stones and stent removal should be rescheduled. 5 guidelines discussed laparoscopic and robotic surgery, while
the remaining recommendations focused on the outpatient procedures and consultations. All recommendations represented
expert opinions, with three specifically endorsed by professional societies. Only the European Association of Urology
guidelines provided evidence-based levels of evidence (mostly level 3 evidence).

•

Triaging office-based urologic procedures during the COVID-19 pandemic

Recommendations for how long various urology procedures may be delayed (if at all). Procedures considered: diagnostic
cystoscopy, surveillance cystoscopy, intravesical instillations for bladder cancer, prostate biopsies and administration of
androgen deprivation, cystoscopy with ureteral stent removal, Foley and suprapubic catheter exchanges, urodynamics.

Vaccination
•

European considerations about HPV vaccination, screening, colposcopy, and surgery
BMJ: The joint advice from the European Federation for Colposcopy (EFC) and the European Society of Gynecological
Oncology (ESGO) suggest the following. Human papillomavirus (HPV) vaccination and cervical cancer screening may continue
in countries with no cases or sporadic cases of COVID-19. However, when health professionals involved in primary/secondary
prevention of cervical cancer are engaged in COVID-19 preparation and response measures, HPV vaccination and screening
activities may be halted. Vaccination and screening programs should be delayed in countries with clusters of cases and/or
community transmission of COVID-19 as long as national or regional authorities in charge of COVID-19 control judge that
mobility of the girls/women of the target population and healthcare givers must be restricted to minimize SARS-CoV-2
transmission. Careful planning is needed to handle the backlogs accumulated due to the COVID-19 measures to minimize
drops in mid- and long-term population coverage. Measures should be taken to complete the vaccination schedule for girls
or young women who have already started HPV vaccination, assuring an interval less than 12–15 months from the first dose.

Vascular
•

Spanish consensus on management of vascular and interventional radiology departments
A consensus was developed by a group of Spanish interventional radiology senior experts. Avoid the coincidence of incoming
and outgoing patients, and minimize waiting periods in the preparation room. The transfer from the hospitalization room, ER
or ICU must be done with the patient covered with a surgical mask that will be used throughout the intervention and its
subsequent return transfer. The order lies or porters responsible for moving the patient must also be equipped with
protective gear. In the preparation room, the patient should be asked about possible respiratory symptoms and his/her
temperature should be measured. Keep the doors of the interventional suite always closed. Only the basic material should be
kept in the interventional suite. Immobile or essential equipment must be covered with plastic covers. Surgical gowns or
gloves must never leave the interventional suite. You cannot stay or enter in the interventional suite without wearing the
FPP2-3 mask/respirator when aCOVID-19 patient is being treated. Wash your hands as many times as necessary with an
alcohol-based solution or hydroalcoholic gel. There is evidence of drug interactions with experimental COVID-19 therapies.

•

Italian Society on Thrombosis and Haemostasis recommendations on haemostasis
Italian Society on Thrombosis and Haemostasis provides recommendations, based on expert consensus, for the management
of the haemostasis derangement in COVID-19 patients.

•

Monitor hemoglobin in COVID-19 patients: evidence from a meta-analysis
Meta-analysis of 4 studies show in 3/4 that hemoglobin was significantly lower in COVID patients with severe disease than
with milder forms, yielding a weighted mean difference of −7.1 g/L; (95% CI, −8.3 to−5.9 g/L). Advise initial assessment and
longitudinal monitoring of hemoglobin, and urge research to assess whether transfusion support may reduce morbidity and
mortality.

•

Abnormal coagulation has poor prognosis: caution with DIC and extracorporeal membrane oxygenation
The authors warn that patients with severe COVID-19 are at greater risk of disseminated intravascular coagulation (DIC)
which may be further complicated by the effects of the extracorporeal membrane oxygenation (ECMO) circuit and the
combination may increase thrombo-hemorrhagic morbidity. Careful correction of the DIC, and systemic anticoagulation will
be required, and standard protocols may need adapting to this new disorder.

•

Society of Thrombosis and Haemostasis guidelines on coagulopathy management in COVID-19
The International Society of Thrombosis and Haemostasis provides the guidelines for risk stratification at admission for a
COVID-19 patient and management of coagulopathy which may develop in some of these patients, based on easily available
laboratory parameters.

•

Vascular surgery department adjustments during COVID-19 pandemic
Portuguese report on managing the largest Lisbon clinic's vascular surgery department.

•

Diagnosis and treatment of suspected venous thromboembolism during COVID-19
This article summarizes a broad institutional consensus focusing on evaluation and recommended empirical therapy for
COVID-19 patients. A committee was comprised of vascular thrombosis experts, vascular surgeons, vascular medicine
physicians, and vascular technologist.

•

Points to consider before transfusion of convalescent plasma as a treatment option
COVID-19 plasma should be managed as an experimental therapy consistent with ethical and legal safeguards. Even if used
empirically it is vital to ensure monitoring of patient clinical and laboratory indicators. Collection and retention of blood
specimens from both donors and recipients (pre- and post- treatment) should be performed to permit retrospective
determination of the characteristics of an effective product and dosage, and the characteristics of patients most likely to
benefit. General information on rationale and approach to use of convalescent plasma in COVID-19 can be found here .

•

Withhold oral anticoagulants from antiviral-treated patients: alarming increase in drug plasma levels
A series of inpatient cases of SARS-CoV-2 is reported. The patients were given antiviral drugs without stopping direct oral
anticoagulant (DOAC) therapy. DOAC plasma levels were measured and results compared with those recorded before
hospitalization. DOAC patients treated with antiviral drugs showed an alarming increase in DOAC plasma levels. In order to
prevent bleeding complications, the authors believe that physicians should consider withholding DOACs from patients with
SARS-CoV-2 and replacing them with alternative parenteral antithrombotic strategies for as long as antiviral agents are
deemed necessary and until discharge.

•

Eligibility criteria for donors of convalescent plasma in Italy
Int J Transfus Med outlines a protocol for selecting a donor for convalescent plasma.

Other
•

International comparison of guidelines for managing neonates during pandemic
Nature: The authors performed an analysis of the early, quasi ad hoc process of national and local guidelines from 20
countries developed for managing neonates born to SARS-CoV-2 positive mothers during the month of March 2020. Disease
burden varied between countries at the time of analysis. In most countries, asymptomatic infants were allowed to stay with
the mother and breastfeed with hygiene precautions. Discrepancies were detected between national guidance regarding
triaging, use of personal protection equipment, viral testing, and visitor policies. Local protocols deviated from the national
guidelines.

•

The guidelines on convalescent plasma use: differences between high and low-middle income countries
VoxSanguinis: A multidisciplinary, geographically representative group of individuals with expertise spanning transfusion
medicine, infectious diseases and hematology has developed the guidance for COVID-19 convalescent plasma (CCP) use.
Three subgroups (i.e. donor, product and patient) were established based on self-identified expertise and interest. A series of
questions pertaining to each domain was devised and addressed by the subgroups, based on the best available evidence.
Here, the donor and product-related challenges are summarized and contrasted between high-income countries (HICs) and
low-middle income countries (LMICs). Early challenges in HICs were related to recruitment and qualification of sufficient
donors to meet the growing demand. Antibody testing also posed a specific obstacle given the lack of standardization,
variable performance of the assays in use and uncertain interpretation of results. In LMICs, an extant transfusion deficit,
suboptimal models of donor recruitment (e.g. reliance on replacement and paid donors), limited laboratory capacity for predonation qualification and operational considerations could impede wide adoption. There has been wide scale adoption of
CCP in many HICs, which could increase if the clinical trials show its efficacy. By contrast, LMICs, having received little
attention, require locally applicable strategies for adoption of CCP.

•

Nutritional management of COVID-19 patients in a rehabilitation unit

Collaboration between the Rehabilitation Unit of the San Raffaele Scientific Institute and the dietetics service created an
interdisciplinary and integrated management of the nutritional status of COVID-19 patients, based on the latest scientific
data. Here the authors report their three-step nutritional protocol: 1) nutritional assessment and malnutrition screening; 2)
setting the nutritional treatment; 3) continuous monitoring.

•

COVID-19 -unrelated clinical trials continue despite the pandemic
Researcher from the University of North Carolina shares his experience of continuing HIV clinical trials despite COVID-19
pandemic: study teams have bought and shipped protective equipment to personnel at clinical trial sites, secured special
permits where necessary for trial participants to leave their homes for medical visits, and arranged their private
transportation to avoid public buses. Many institutions have stratified their ongoing clinical studies and halted only those in
which patients didn't stand to benefit directly.

•

Diluted bleach recommended for COVID-19 disinfection
With rapidly diminishing availability of commercial cleaning supplies, simple diluted bleach, which is readily available, can
effectively disinfect our clinics, homes, and environment to prevent sustained transmission from inanimate objects. As with
many disinfects, minimizing long term skin contact and ensuring good ventilation can minimize clinical toxicity.

•

Survivors can help and should be well-documented
All survivors should be well-documented. Plasma can be used for neutralizing antibodies and stored in blood banks and
distributed across countries so that it can be delivered when need arises. In emergency situations, recovered subjects who
are negative for COVID-19 can be considered for voluntary temporary employment at sensitive locations such as hospitals
and airport as per their capability and skill set. 50%-66% of the population is required to be immune to achieve herd
immunity.

•

Interim guidance for homeless service providers to plan and respond to COVID-19
CDC has developed recommendations for homeless service providers, including overnight emergency shelters, day shelters,
and meal service providers and how to protect their staff, clients, and guests.

•

CDC recommends early testing in homeless shelters to help prevent spread
Use PPE and apply social distancing. In shelters with identified clustered cases (>=2 cases in 2 weeks), consider testing all
residents and staff regardless of symptoms. Consider regular testing in shelters before identifying clusters.

•

CDC guidelines for US homeless shelters
COVID-19 testing was conducted in 19 homeless shelters, both residents and staff, in several major US cities. Of 1,192
residents and 313 staff, positive tests found in 17% of residents; 17% of staff in Seattle; 36%; 30% in Boston, and 66%; 16% in
San Francisco. CDC recommends infection control, social distancing (beds 6ft apart), and face covering at shelters. If
available, regular testing.

•

Guidelines for repurposing anesthetic machines as ICU ventilators
New guidelines have been produced by the American Society of Anesthesiologists and the Anesthesia Patient Safety
Foundation. A Canadian group has modified these guidelines and produced their own: click on link here. In addition,
strategies to protect anesthetic machines from contamination have also been published by the Anesthesia Patient Safety
Foundation: click on link here.

•

The video instructions on how to obtain a nasopharyngeal swab specimen
The 5-minute video shows how to perform the procedure.

•

The guidance for nuclear medicine departments
The guidance is provided based on the systematic review of available literature and the contribution of a panel of
international experts of the International Atomic Energy Agency (IAEA). The principles are described for adapting the
standard operating procedures until more detailed guidance is prepared by the IAEA.

•

NIH treatment guidelines advise against exposure prophylaxis

NIH panel does not recommend any drug for pre- or post-exposure prophylaxis outside of clinical trials. It neither makes
recommendation for any specific antiviral or immunomodulatory treatments, as no drug was proven to be safe and effective.
Certain therapies can be used under investigation (summary of studies provided). They advised against hydroxychloroquineazithromycin due to toxicity, against HIV protease inhibitors due to lack of trial results and unfavorable pharmacodynamics,
against interferons and Janus kinase inhibitors, and against systemic corticosteroids for mechanically ventilated adults with
COVID-19 without ARDS. Low-dose corticosteroids are preferred over no corticosteroids in patients with refractory shock.

•

Korean guidelines for laboratory diagnosis of COVID-19
Korean Society for Laboratory Medicine and the Korea Centers for Disease Prevention and Control propose guidelines for
diagnosing COVID-19 in clinical laboratories. These include the selection of test subjects, selection of specimens, diagnostic
methods, interpretation of test results, and biosafety. The detailed information about specimen handling is provided.

•

Mortality prediction: REMS rapid scoring is more effective than MEWS, especially for patients <65 years
138 medical records of critically ill patients with COVID-19 were analyzed. The authors compared two rapid scoring systems
used on admission in mortality prediction. Performance characteristics of the Rapid Emergency Medicine Score (REMS) was
better than those of the Modified Early Warning Score (MEWS) (area under the ROC curve 0.86 (95% CI: 0.74–0.94) vs. 0.60,
(95% CI 0.46–0.73). For those under 65 y.o. the same parameter for REMS was 0.863 vs. 0.60 for MEWS. An optimal cut‐off
of REMS had a sensitivity of 89.5%, a specificity of 69.8%, a PPV of 39.5%, and a NPV of 96.8%.

•

Healthcare for the elderly: lessons from the COVID-19 outbreak in Italy
The authors' data suggest that Italian national health care system was not suited and prepared to respond to crisis. Geriatric
care teams must be integrated along with infectious disease specialists, pneumologists, and anesthesiologists into the
management of SARS-CoV-2. The GeroCovid Initiative of the Italian Society of Gerontology and Geriatrics aims at expanding
the knowledge of the disease and its impact on health status and needs of care as well as at promoting health care strategies.
Any Geriatric Society or working group can voluntarily join the GeroCovid group at www.sigg.it
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